U.S. patent application number 11/612826 was filed with the patent office on 2007-08-23 for new process for the preparation of oxabispidines.
This patent application is currently assigned to ASTRAZENECA AB. Invention is credited to Lal Cheema, David Cladingboel, Rhona Sinclair.
Application Number | 20070197519 11/612826 |
Document ID | / |
Family ID | 20283781 |
Filed Date | 2007-08-23 |
United States Patent
Application |
20070197519 |
Kind Code |
A1 |
Cheema; Lal ; et
al. |
August 23, 2007 |
New Process For The Preparation Of Oxabispidines
Abstract
There is provided a process for the preparation of a compound of
formula (I): which process comprises reaction of a compound of
formula (TI): with either a compound of formula (ITT): or
acrylamide, followed, in the latter case, by reaction of the
resulting intermediate of formula (IV): with an alcohol of formula
R.sup.2.dbd.OH and an agent that promotes, or agents that in
combination promote, rearrangement and oxidation of the compound of
formula IV to an intermediate isocyanate, which may then react with
the alcohol of formula R.sup.2.dbd.OH, and wherein R.sup.1, R.sup.2
and R.sup.16 have meanings given in the description.
Inventors: |
Cheema; Lal;
(Leicestershire, GB) ; Cladingboel; David;
(Leicestershire, GB) ; Sinclair; Rhona;
(Leicestershire, GB) |
Correspondence
Address: |
Pepper Hamilton LLP
500 Grant Street
One Mellon Bank Center, 50th Floor
Pittsburgh
PA
15219-2502
US
|
Assignee: |
ASTRAZENECA AB
S-151 85
Sodertalje
SE
|
Family ID: |
20283781 |
Appl. No.: |
11/612826 |
Filed: |
December 19, 2006 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10474593 |
Apr 22, 2004 |
7169921 |
|
|
PCT/SE02/00727 |
Apr 12, 2002 |
|
|
|
11612826 |
Dec 19, 2006 |
|
|
|
Current U.S.
Class: |
514/230.5 ;
544/74 |
Current CPC
Class: |
Y02P 20/55 20151101;
A61P 9/06 20180101; C07D 498/08 20130101 |
Class at
Publication: |
514/230.5 ;
544/074 |
International
Class: |
C07D 498/04 20060101
C07D498/04; A61K 31/5383 20060101 A61K031/5383 |
Foreign Application Data
Date |
Code |
Application Number |
Apr 12, 2001 |
SE |
0101324-2 |
Claims
1. A process for the preparation of a compound of formula I,
##STR22## wherein R.sup.1 represents H, an amino protective group
or a structural fragment of formula la, ##STR23## in which R.sup.3
represents H, halo, C.sub.1-6 alkyl, --OR.sup.6,
-E-N(R.sup.7)R.sup.8 or, together with R.sup.4, represents .dbd.O;
R.sup.4 represents H, C.sub.1-6 alkyl or, together with
R.sup.3represents .dbd.O; R.sup.6 represents H, C.sub.1-6 alkyl,
-E-aryl, -E-Het.sup.1, --C(O)R.sup.9a, --C(O)OR.sup.9b or
--C(O)N(R.sup.10a)R.sup.10b; R.sup.7 represents H, C.sub.1-6 alkyl,
-E-aryl, -E-Het.sup.1, --C(O)R.sup.9a, --C(O)OR.sup.9b,
--S(O).sub.2R.sup.9c, --[C(O)].sub.pN(R.sup.10a)R.sup.10b or
--C(NH)NH.sub.2; R.sup.8 represents H, C.sub.1-6 alkyl, -E-aryl or
--C(O)R.sup.9d; R.sup.9a to R.sup.9d independently represent, at
each occurrence, C.sub.1-6 alkyl (optionally substituted and/or
terminated by one or more substituents selected from halo, aryl and
Het.sup.2), aryl, Het.sup.3, or R.sup.9a and R.sup.9d independently
represent H; R.sup.10a and R.sup.10b independently represent, at
each occurrence, H or C.sub.1-6 alkyl (optionally substituted
and/or terminated by one or more substituents selected from halo,
aryl and Het.sup.4), aryl, Het.sup.5, or together represent
C.sub.3-6 alkylene, optionally interrupted by an O atom; E
represents, at each occurrence, a direct bond or C.sub.1-4
alkylene; p represents 1 or 2; A represents -G-, -J-N(R.sup.11)--
or -J-O-- (in which latter two groups, N(R.sup.11)-- or O-- is
attached to the carbon atom bearing R.sup.3 and R.sup.4); B
represents -Z-, -Z-N(R.sup.12)--, --N(R.sup.12)-Z-, -Z-S(O).sub.n--
or -Z-O-- (in which latter two groups, Z is attached to the carbon
atom bearing R.sup.3 and R.sup.4; G represents a direct bond or
C.sub.1-6 alkylene; J represents C.sub.2-6 alkylene; Z represents a
direct bond or C.sub.1-4 alkylene; R.sup.11 and R.sup.12
independently represent H or C.sub.1-6 alkyl; n represents 0, 1 or
2; R.sup.5 represents phenyl or pyridyl, both of which groups are
optionally substituted by one or more substituents selected from
--OH, cyano, halo, nitro, C.sub.1-6 alkyl (optionally terminated by
--N(H)C(O)OR.sup.13a), C.sub.1-6 alkoxy, --N(R.sup.14a)R.sup.14b,
--C(O)R.sup.14c, --C(O)OR.sup.14d, --C(O)N(R.sup.14e)R.sup.14f,
--N(R.sup.14g)C(O)R.sup.14h,
--N(R.sup.14i)C(O)N(R.sup.14j)R.sup.14k,
--N(R.sup.14m)S(O).sub.2R.sup.13b, --S(O).sub.2R.sup.13c and/or
--OS(P).sub.2R.sup.13d; R.sup.13a to R.sup.13d independently
represent C.sub.1-6 alkyl; R.sup.14a and R.sup.14b independently
represent H, C.sub.1-6 alkyl or together represent C.sub.3-6
alkylene, resulting in a four- to seven-membered
nitrogen-containing ring; R.sup.14c to R.sup.14m independently
represent H or C.sub.1-6 alkyl; and Het.sup.1 to Het.sup.5
independently represent, at each occurrence, five- to
twelve-membered heterocyclic groups containing one or more
heteroatoms selected from oxygen, nitrogen and/or sulfur, which
heterocyclic groups are optionally substituted by one or more
substituents selected from .dbd.O, --OH, cyano, halo, nitro,
C.sub.1-6 alkyl, C.sub.1-6 alkoxy, aryl, aryloxy,
--N(R.sup.15a)R.sup.15b, --C(O)R.sup.15c, --C(O)R.sup.15d,
--C(O)N(R.sup.15e)R.sup.15f, --N(R.sup.15g)C(O)R.sup.15h and
--N(R.sup.15i)S(O).sub.2R.sup.15j; R.sup.15a to R.sup.15i
independently represent C.sub.1-6 alkyl, aryl or R.sup.15a to
R.sup.15i independently represent H; provided that: (a) when
R.sup.4 represents H or C.sub.1-4 alkyl; and A represents
-J-N(R.sup.11)-- or -J-O--; then B does not represent
--N(R.sup.12)--, --S(O).sub.n--, --O-- or --N(R.sup.12)-Z- (in
which latter group --N(R.sup.12) is attached to the carbon atom
bearing R.sup.3 and R.sup.4); (b) when R.sup.3 represent OR.sup.6
or -E-N(R.sup.7)R.sup.8 in which E represents a direct bond, then:
(i) A does not represent a direct bond, -J-N(R.sup.11)-- or J-O--;
and (ii) B does not represent --N(R.sup.12)--, --S(O).sub.n--,
--O-- or --N(R.sup.12)-Z- (in which latter group --N(R.sup.12) is
attached to the carbon atom bearing R.sup.3 and R.sup.4); and
R.sup.2 represents C.sub.1-6 alkyl (optionally substituted and/or
terminated by one or more substituents selected from --OH, halo,
cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy
group, unless otherwise specified, is optionally substituted by one
or more of --OH, cyano, halo, nitro, C.sub.1-6 alkyl, C.sub.1-6
alkoxy, --N(R.sup.14a)R.sup.14b, --C(O)R.sup.14c, --C(O)OR.sup.14d,
--C(O)N(R.sup.14c)R.sup.14f, --N(R.sup.14g)C(O)R.sup.14h,
--N(R.sup.14m)S(O)R.sup.2R.sup.13b, --S(O).sub.2R.sup.13c and/or
--OS(O).sub.2R.sup.13d; which process comprises reaction of a
compound of formula II, ##STR24## wherein as defined above, with
either: (i) a compound of formula ITT, ##STR25## wherein R.sup.16
represents unsubstituted C.sub.1-4 alkyl, C.sub.1-4 perfluoroalkyl
or phenyl, which latter group is optionally substituted by one or
more substituents selected from C.sub.1-6 alkyl, halo, nitro and
C.sub.1-6 alkoxy, and R.sup.2 is as defined above; or (ii)
acrylamide, followed by reaction of the resulting intermediate of
formula IV, ##STR26## wherein R.sup.1 as defined above, with an
alcohol of formula R.sup.2--OH and an agent that promotes, or
agents that in combination promote, rearrangement and oxidation of
the compound of formula IV to an intermediate isocyanate, which may
then react with the alcohol of formula R.sup.2--OH, wherein R.sup.2
is as defined above.
2-34. (canceled)
35. A process for the preparation of a compound of formula I, as
defined in claim 1, in which R.sup.1 represents H, which process
comprises removal of the amino protective group from a
corresponding compound of formula I in which R.sup.1 represents an
amino protective group.
36-77. (canceled)
Description
FIELD OF THE INVENTION
[0001] This invention relates to a novel process for the
preparation of oxabispidine compounds that bear a
N-2-(alkoxycarbonylamino)ethyl substituent.
PRIOR ART
[0002] The number of documented compounds including the
9-oxa-3,7-diazabicyclo-[3.3.1]nonane (oxabispidine) structure is
very few. As a result, there are very few known processes that are
specifically adapted for the preparation of oxabispidine
compounds.
[0003] Certain oxabispidine compounds are disclosed in Chem. Ber.
96(11), 2827 (1963) as intermediates in the synthesis of
1,3-diaza-6-oxa-adamantanes.
[0004] Hemiacetals (and related compounds) having the oxabispidine
ring structure are disclosed in J. Org. Chem. 31, 277 (1966), ibid.
61(25), 8897 (1996), ibid. 63(5), 1566 (1998) and ibid. 64(3), 960
(1999) as unexpected products from the oxidation of
1,5-diazacyclooctane-1,3-diols or the reduction of
1,5-diazacyclooctane-1,3-diones.
[0005] 1,3-Dimethyl-3,7-ditosyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
is disclosed in J. Org. Chem. 32, 2425 (1967) as a product from the
attempted acetylation of
trans-1,3-dimethyl-1,5-ditosyl-1,5-diazacyclooctane-1,3-diol.
[0006] None of the above-mentioned documents disclose or suggest
the synthesis of oxabispidine compounds that bear a
N-2-(alkoxycarbonylamino)ethyl substituent.
[0007] International patent application WO 01/28992 describes the
synthesis of a wide range of oxabispidine compounds, which
compounds are indicated as being useful in the treatment of cardiac
arrhythmias. Amongst the compounds disclosed are a number that bear
a N-2-(tert-butoxycarbonylamino)ethyl substituent. However, there
is no disclosure in WO 01/28992 of processes for introducing
N-2-(alkoxycarbonylamino)ethyl substituents into the oxabispidine
nucleus that comprise either: (a) nucleophilic substitution of a
sulfonate group from a 2-(alkoxycarbonylamino)ethyl sulfonate; or
(b) reaction with acrylamide, followed by rearrangement of the
resulting primary amide to an isocyanate intermediate, and
subsequent reaction of that intermediate with an alcohol.
[0008] We have now found, surprisingly, that oxabispidine compounds
that bear a N-2-(alkoxycarbonylamino)ethyl substituent may be
prepared readily from the corresponding N-unsubstituted
oxabispidines via such processes.
DESCRIPTION OF THE INVENTION
[0009] According to a first aspect of the invention there is
provided a process for the preparation of a compound of formula I,
##STR1## wherein R.sup.1 represents H, an amino protective group or
a structural fragment of formula Ia, ##STR2## in which [0010] R
represents H, halo, C.sub.1-6 alkyl, --OR.sup.6,
-E-N(R.sup.7)R.sup.8 or, together with R.sup.4, represents=0;
[0011] R.sup.4represents H, C.sub.1-6 alkyl or, together with
R.sup.3, represents .dbd.O; [0012] R.sup.6 represents H, C.sub.1-6
alkyl, -E-aryl, -E-Het.sup.1, --C(O)R.sup.9a, --C(O)OR.sup.9b or
--C(O)N(R.sup.10a)R.sup.10b; [0013] R.sup.7 represents H, C.sub.1-6
alkyl, -E-aryl, -E-Het.sup.1, --C(O)R.sup.9a, --C(O)OR.sup.9b,
--S(O).sub.2R.sup.9c, --[C(O)].sub.pN(R.sup.10a)R.sup.10b or
--C(NH)NH.sub.2; [0014] R.sup.8 represents H, C.sub.1-6 alkyl,
-E-aryl or --C(O)R.sup.9d; [0015] R.sup.9a to R.sup.9d
independently represent, at each occurrence when used herein,
C.sub.1-6 alkyl (optionally substituted and/or terminated by one or
more substituents selected from halo, aryl and Het.sup.2), aryl,
Het.sup.3, or R.sup.9a and R.sup.9d independently represent H;
[0016] R.sup.10a and R.sup.10b independently represent, at each
occurrence when used herein, H or C.sub.1-6 alkyl (optionally
substituted and/or terminated by one or more substituents selected
from halo, aryl and Het.sup.4), aryl, Het.sup.5, or together
represent C.sub.3-6 alkylene, optionally interrupted by an O atom;
[0017] E represents, at each occurrence when used herein, a direct
bond or C.sub.1-4 alkylene; [0018] p represents 1 or 2; [0019] A
represents -G-, -J-N(R.sup.11)-- or -J-O-- (in which latter two
groups, N(R.sup.11)-- or O-- is attached to the carbon atom bearing
R.sup.3 and R.sup.4); [0020] B represents -Z-, -Z-N(R.sup.12)--,
--N(R.sup.12)-Z-, -Z-S(O).sub.n-- or -Z-O-- (in which latter two
groups, Z is attached to the carbon atom bearing R.sup.3and
R.sup.4); [0021] G represents a direct bond or C.sub.1-6 alkylene;
[0022] J represents C.sub.2-6 alkylene; [0023] Z represents a
direct bond or C.sub.1-4 alkylene; [0024] R.sup.11 and R.sup.12
independently represent H or C.sub.1-6 alkyl; [0025] n represents
0, 1 or 2; [0026] R.sup.5 represents phenyl or pyridyl, both of
which groups are optionally substituted by one or more substituents
selected from --OH, cyano, halo, nitro, C.sub.1-6 alkyl (optionally
terminated by --N(H)C(O)OR.sup.13a), C.sub.1-6 alkoxy,
--N(R.sup.14a)R.sup.14b, C(O)R.sup.14c, --C(O)OR.sup.14d,
--C(O)N(R.sup.14e)R.sup.14f--N(R.sup.14g)C(O)R.sup.14h,
--N(R.sup.14i)C(O)N(R.sup.14j)R.sup.14k,
--N(R.sup.14m)S(O).sub.2R.sup.13b, --S(O).sub.2R.sup.13c and/or
--OS(O).sub.2R.sup.13d, [0027] R.sup.13a to R.sup.13d independently
represent C.sub.1-6 alkyl; [0028] R.sup.14a and R.sup.14b
independently represent H, C.sub.1-6 alkyl or together represent
C.sub.3-6 alkylene, resulting in a four- to seven-membered
nitrogen-containing ring; [0029] R.sup.14c to R.sup.14m
independently represent H or C.sub.1-6 alkyl; and
[0030] Het.sup.1 to Het.sup.5 independently represent, at each
occurrence when used herein, five- to twelve-membered heterocyclic
groups containing one or more heteroatoms selected from oxygen,
nitrogen and/or sulfur, which heterocyclic groups are optionally
substituted by one or more substituents selected from .dbd.O, --OH,
cyano, halo, nitro, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, aryl,
aryloxy, --N(R.sup.15a)R.sup.15b, --C(O)R.sup.15c,
--C(O)OR.sup.15d, --C(O)N(R.sup.15e)R.sup.15f,
--N(R.sup.15g)C(O)R.sup.15h and --N(R.sup.15i)S(O).sub.2R.sup.15j;
[0031] R.sup.15a to R.sup.15i independently represent C.sub.1-6
alkyl, aryl or R.sup.15a to R.sup.15i independently represent H;
[0032] provided that: [0033] (a) when R.sup.4 represents H or
C.sub.1-4 alkyl; and [0034] A represents -J-N(R.sup.11)-- or
-J-O--; [0035] then B does not represent --N(R.sup.12)--,
--S(O).sub.n--, --O-- or --N(R.sup.12)-Z- (in which latter group
--N(R.sup.12) is attached to the carbon atom bearing R.sup.3 and
R.sup.4); [0036] (b) when R.sup.3 represents --OR.sup.6 or
-E-N(R.sup.7)R.sup.8 in which E represents a direct bond, then:
[0037] (i) A does not represent a direct bond, -J-N(R.sup.11)-- or
-J-O--; and [0038] (ii) B does not represent --N(R.sup.12)--,
--S(O).sub.n--, --O-- or --N(R.sup.12)-Z- (in which latter group
--N(R.sup.12) is attached to the carbon atom bearing R.sup.3 and
R.sup.4); and [0039] R.sup.2 represents C.sub.1-6 alkyl (optionally
substituted and/or terminated by one or more substituents selected
from --OH, halo, cyano, nitro and aryl) or aryl, [0040] wherein
each aryl and aryloxy group, unless otherwise specified, is
optionally substituted; [0041] which process comprises reaction of
a compound of formula II, ##STR3## [0042] wherein R.sup.1 is as
defined above, with either: [0043] (i) a compound of formula III,
##STR4## [0044] wherein R.sup.16 represents unsubstituted C.sub.1-4
alkyl, C.sub.1-4 perfluoroalkyl or phenyl, which latter group is
optionally substituted by one or more substituents selected from
C.sub.1-6 alkyl, halo, nitro and C.sub.1-6 alkoxy, and R.sup.2 is
as defined above; or [0045] (ii) acrylamide, followed by reaction
of the resulting intermediate of formula IV, ##STR5## [0046]
wherein R.sup.1 is as defined above, with an alcohol of formula
R.sup.2--OH and an agent that promotes, or agents that in
combination promote, rearrangement and oxidation of the compound of
formula IV to an intermediate isocyanate, which may then react with
the alcohol of formula R.sup.2--OH, wherein R.sup.2 is as defined
above, and which process is referred to hereinafter as "the process
of the invention".
[0047] Unless otherwise specified, alkyl groups and alkoxy groups
as defined herein may be straight-chain or, when there is a
sufficient number (i.e. a minimum of three) of carbon atoms be
branched-chain, and/or cyclic. Further, when there is a sufficient
number (i.e. a minimum of four) of carbon atoms, such alkyl and
alkoxy groups may also be part cyclic/acyclic. Such alkyl and
alkoxy groups may also be saturated or, when there is a sufficient
number (i.e. a minimum of two) of carbon atoms, be unsaturated
and/or interrupted by one or more oxygen and/or sulfur atoms.
Unless otherwise specified, alkyl and alkoxy groups may also be
substituted by one or more halo, and especially fluoro, atoms.
[0048] Unless otherwise specified, alkylene groups as defined
herein may be straight-chain or, when there is a sufficient number
(i.e. a minimum of two) of carbon atoms, be branched-chain. Such
alkylene chains may also be saturated or, when there is a
sufficient number (i.e. a minimum of two) of carbon atoms, be
unsaturated and/or interrupted by one or more oxygen and/or sulfur
atoms. Unless otherwise specified, alkylene groups may also be
substituted by one or more halo atoms.
[0049] The term "aryl", when used herein, includes C.sub.6-10 aryl
groups such as phenyl, naphthyl and the like. The term "aryloxy",
when used herein includes C.sub.6-10 aryloxy groups such as
phenoxy, naphthoxy and the like. For the avoidance of doubt,
aryloxy groups referred to herein are attached to the rest of the
molecule via the O-atom of the oxy-group. Unless otherwise
specified, aryl and aryloxy groups may be substituted by one or
more substituents including --OH, cyano, halo, nitro, C.sub.1-6
alkyl, C.sub.1-6 alkoxy, --N(R.sup.14a)R.sup.14b, --C(O)R.sup.14c,
--C(O)OR.sup.14dd, --C(O)N(R.sup.14e)R.sup.14f,
N(R.sup.14g)C(O)R.sup.14h, N(R.sup.14m)S(O).sub.2R.sup.13b,
--S(O).sub.2R.sup.13c and/or --OS(O).sub.2R.sup.13d (wherein
R.sup.13b to R.sup.13d and R.sup.14a to R.sup.14m are as
hereinbefore defined). When substituted, aryl and aryloxy groups
are preferably substituted by between one and three
substitutents.
[0050] The term "halo", when used herein, includes fluoro, chloro,
bromo and iodo.
[0051] Het (Het.sup.1 to Het.sup.5) groups that may be mentioned
include those containing 1 to 4 heteroatoms (selected from the
group oxygen, nitrogen and/or sulfur) and in which the total number
of atoms in the ring system are between five and twelve. Het
(Het.sup.1 to Het.sup.5) groups may be fully saturated, wholly
aromatic, partly aromatic and/or bicyclic in character.
Heterocyclic groups that may be mentioned include benzodioxanyl,
benzodioxepanyl, benzodioxolyl, benzofuranyl, benzimidazolyl,
benzomorpholinyl, benzoxazinonyl, benzothiophenyl, chromanyl,
cinnolinyl, dioxanyl, furanyl, imidazolyl, imidazo[1,2-a]pyridinyl,
indolyl, isoquinolinyl, isoxazolyl, morpholinyl, oxazolyl,
phthalazinyl, piperazinyl, piperidinyl, purinyl, pyranyl,
pyrazinyl, pyrazolyl, pyridinyl, pyrimindinyl, pyrrolidinonyl,
pyrrolidinyl, pyrrolinyl, pyrrolyl, quinazolinyl, quinolinyl,
tetrahydropyranyl, tetrahydrofuranyl, thiazolyl, thienyl,
thiochromanyl, triazolyl and the like. Substituents on Het
(Het.sup.1 to Het.sup.5) groups may, where appropriate, be located
on any atom in the ring system including a heteroatom. The point of
attachment of Het (Het.sup.1 to Het.sup.5) groups may be via any
atom in the ring system including (where appropriate) a heteroatom,
or an atom on any fused carbocyclic ring that may be present as
part of the ring system. Het (Het.sup.1 to Het.sup.5) groups may
also be in the N-- or S-oxidised form.
[0052] As used herein, the term "amino protective group" includes
groups mentioned in "Protective Groups in Organic Synthesis",
2.sup.nd edition, T W Greene & P G M Wutz, Wiley-Interscience
(1991), in particular those indexed at the start of the chapter
entitled "Protection for the Amino Group" (see pages 309 to 315) of
that reference, the disclosure in which document is hereby
incorporated by reference.
[0053] Specific examples of amino protective groups thus include:
[0054] (a) those which form carbamate groups (e.g. to provide
methyl, cyclopropylmethyl, 1-methyl-1-cyclopropylmethyl,
diisopropylmethyl, 9-fluorenylmethyl, 9-(2-sulfo)fluorenylmethyl,
2-furanylmethyl, 2,2,2-trichloroethyl, 2-haloethyl,
2-trimethylsilylethyl, 2-methylthioethyl, 2-methylsulfonylethyl,
2(p-toluenesulfonyl)ethyl, 2-phosphonioethyl, 1,1-dimethylpropynyl,
1,1-dimethyl-3-(N,N-dimethylcarboxamido)-propyl,
1,1-dimethyl-3-(N,N-diethylamino)-propyl,
1-methyl-1-(1-adamantyl)ethyl, 1-methyl-1-phenylethyl,
1-methyl-1-(3,5-dimethoxyphenyl)ethyl,
1-methyl-1-(4-biphenylyl)-ethyl,
1-methyl-1-(p-phenylazophenyl)ethyl, 1,1-dimethyl-2-haloethyl,
1,1-dimethyl-2,2,2-trichloroethyl, 1,1-dimethyl-2-cyanoethyl,
isobutyl, t-butyl, t-amyl, cyclobutyl, 1-methylcyclobutyl,
cyclopentyl, cyclohexyl, 1-methylcyclohexyl, 1-adamantyl,
isobornyl, vinyl, allyl, cinnamyl, phenyl, 2,4,6-tri-t-butylphenyl,
m-nitrophenyl, S-phenyl, 8-quinolinyl, N-hydroxypiperidinyl,
4-(1,4-dimethylpiperidinyl), 4,5-diphenyl-3-oxazolin-2-one, benzyl,
2,4,6-trimethylbenzyl, p-methoxybenzyl, 3,5-dimethoxybenzyl,
p-decyloxybenzyl, p-nitrobenzyl, o-nitrobenzyl,
3,4-dimethoxy-6-nitrobenzyl, p-bromobenzyl, chlorobenzyl,
2,4-dichloro-benzyl, p-cyanobenzyl,
o-(N,N-dimethylcarboxamidobenzyl)benzyl, m-chloro-p-acyloxybenzyl,
p-(dihydroxyboryl)benzyl, p-(phenylazo)benzyl,
p-(p'-methoxyphenylazo)benzyl, 5-benzisoxazolylmethyl,
9-anthrylmethyl, diphenylmethyl, phenyl(o-nitrophenyl)methyl,
di(2-pyridyl)methyl, 1-methyl-1-(4-pyridyl)-ethyl, isonicotinyl, or
S-benzyl, carbamate groups); [0055] (b) those which form amide
groups (e.g. to provide N-formyl, N-acetyl, N-chloroacetyl,
N-dichloro-acetyl, N-trichloroacetyl, N-trifluoroacetyl,
N-o-nitrophenylacetyl, N-o-nitrophenoxyacetyl, N-acetoacetyl,
N-acetylpyridinium, N-3-phenylpropionyl,
N-3-(p-hydroxyphenyl)-propionyl, N-3-(o-nitro-phenyl)propionyl,
N-2-methyl-2-(o-nitro-phenoxy)propionyl,
N-2-methyl-2-(o-phenylazophenoxy)propionyl, N-4-chlorobutyryl,
N-isobutyryl, N-o-nitrocinnamoyl, N-picolinoyl,
N-(N'-acetyl-methionyl), N-(N'-benzoylphenylalanyl), N-benzoyl,
N-p-phenyl-benzoyl, N-p-methoxybenzoyl, N-o-nitrobenzoyl, or
N-o-(benzoyloxy-methyl)benzoyl, amide groups); [0056] (c) those
which form N-alkyl groups (e.g. N-allyl, N-phenacyl,
N-3-acetoxypropyl, N-(4-nitro-1-cyclohexyl-2-oxo-pyrrolin-3-yl),
N-methoxymethyl, N-chloroethoxymethyl, N-benzyloxymethyl,
N-pivaloyloxymethyl, N-2-tetrahydropyranyl, N-2,4-dinitrophenyl,
N-benzyl, N-3,4-di-methoxybenzyl, N-o-nitrobenzyl,
N-di(p-methoxyphenyl)methyl, N-triphenylmethyl,
N-(p-methoxyphenyl)-diphenylmethyl, N-diphenyl-4-pyridylmethyl,
N-2-picolyl N'-oxide, or N-dibenzosuberyl, groups); [0057] (d)
those which form N-phosphinyl and N-phosphoryl groups (e.g.
N-diphenylphosphinyl, N-dimethylthiophosphinyl,
N-diphenyl-thiophosphinyl, N-diethyl-phosphoryl,
N-dibenzylphosphoryl, or N-phenylphosphoryl, groups); [0058] (e)
those which form N-sulfenyl groups (e.g. N-benzenesulfenyl,
N-o-nitrobenzenesulfenyl, N-2,4-dinitrobenzenesulfenyl,
N-pentachloro-benzenesulfenyl, N-2-nitro-4-methoxybenzenesulfenyl,
or N-triphenylmethylsulfenyl, groups); [0059] (f) those which form
N-sulfonyl groups (e.g. N-benzenesulfonyl,
N-p-nitrobenzenesulfonyl, N-p-methoxybenzenesulfonyl,
N-2,4,6-trimethylbenzene-sulfonyl, N-toluenesulfonyl,
N-benzylsulfonyl, N-p-methylbenzyl-sulfonyl,
N-trifluoromethylsulfonyl, or N-phenacylsulfonyl, groups); and
[0060] (g) that which forms the N-trimethylsilyl group.
[0061] Preferred amino protective groups include those which
provide the carbamate, N-alkyl and N-sulfonyl groups mentioned
above. Particular protecting groups thus include
tert-butoxycarbonyl (to form a tert-butylcarbamate group),
benzenesulfonyl, 4-nitrobenzenesulfonyl, 3,4-dimethoxybenzyl,
o-nitrobenzyl and, especially, benzyl groups.
[0062] The skilled person will appreciate that the conversion of
the intermediate of formula IV to the compound of formula I is a
transformation that is akin to a classical "Hofmann" rearrangement,
except that, in the process of the invention, the intermediate
isocyanate compound is "trapped" with an alcohol of formula
R.sup.2OH, as opposed to water. In this respect, agents that may be
used to effect the rearrangement/oxidation process include
combinations of halogenating agents and bases, such as a
combination of a brominating agent and a base. Suitable
halogenating agents include any source of "electrophilic" halogen
(e.g. N-halosuccinimides and halogens).
[0063] Other agents that may be used to effect the above-mentioned
rearrangement include Pb(OAc).sub.4.
[0064] Preferred values of R.sup.1 include an amino protective
group, or a structural fragment of formula Ia in which: [0065]
R.sup.3 represents H, halo, C.sub.1-3 alkyl, --OR.sup.6,
--N(H)R.sup.7 or, together with R.sup.4, represents .dbd.O; [0066]
R.sup.4 represents H, C.sub.1-3 alkyl or, together with R.sup.3,
represents=O; [0067] R.sup.6 represents H, C.sub.1-6 alkyl,
-E-phenyl (which phenyl group is optionally substituted by one or
more substituents selected from cyano, halo, nitro, C.sub.1-4 alkyl
and C.sub.1-4 alkoxy) or -E-Het; [0068] R.sup.7 represents H,
C.sub.1-6 alkyl, -E-phenyl (which phenyl group is optionally
substituted by one or more substituents selected from cyano, halo,
nitro, C.sub.1-4 alkyl and C.sub.1-4 alkoxy), --C(O)R.sup.9a,
--C(O)OR.sup.9b, --S(O).sub.2R.sup.9c, --C(O)N(R.sup.10a)R.sup.10b
or --C(NH)NH.sub.2; [0069] R.sup.9a to R.sup.9c independently
represent C.sub.1-6 alkyl, or R.sup.9a represents H; [0070]
R.sup.10a and R.sup.10b independently represent H or C.sub.1-4
alkyl; [0071] E represents, at each occurrence when used herein, a
direct bond or C.sub.1-2 alkylene; [0072] A represents -G-,
-J-N(R.sup.11)-- or -J-O-- (in which latter two groups,
N(R.sup.11)-- or O-- is attached to the carbon atom bearing R.sup.3
and R.sup.4); [0073] B represents -Z-, -Z-N(R.sup.12)--,
-Z-S(O).sub.n-- or -Z-O--; [0074] G represents C.sub.1-4 alkylene;
[0075] J represents C.sub.2-4 alkylene; [0076] Z represents a
direct bond or C.sub.1-3 alkylene; [0077] R.sup.11 and R.sup.12
independently represent H or C.sub.1-4 alkyl; [0078] n represents 0
or 2; [0079] R.sup.5 represents phenyl or pyridyl, both of which
groups are optionally substituted by one or more substituents
selected from cyano, halo, nitro, C.sub.1-6 alkyl, C.sub.1-6
alkoxy, --NH.sub.2, --C(O)N(R.sup.14e)R.sup.14f,
--N(R.sup.14g)C(O)R.sup.14h and --N(R.sup.14m)S(O).sub.2R.sup.13b;
[0080] R.sup.13b represents C.sub.1-3 alkyl; [0081] R.sup.14e to
R.sup.14m independently represent, at each occurrence when used
herein, H or C.sub.1-4 alkyl; [0082] Het.sup.1 to Het.sup.5 are
optionally substituted by one or more substituents selected from
.dbd.O, cyano, halo, nitro, C.sub.1-4 alkyl, C.sub.1-4 alkoxy,
--N(R.sup.15a)R.sup.15b, --C(O)R.sup.15c, or --C(O)OR.sup.15d;
[0083] R.sup.15a to R.sup.15d independently represent H, C.sub.1-4
alkyl or aryl.
[0084] Values of R.sup.1 that are more preferred include an amino
protective group, or a structural fragment of formula Ia in which:
[0085] R.sup.3 represents H, methyl, --OR.sup.6 or --N(H)R.sup.7;
[0086] R.sup.4 represents H or methyl; [0087] R.sup.6 represents H,
C.sub.1-2 alkyl or phenyl (which phenyl group is optionally
substituted by one or more substituents selected from cyano and
C.sub.1-4 alkoxy); [0088] R.sup.7 represents H, C.sub.1-2 alkyl,
phenyl (which phenyl group is optionally substituted by one or more
substituents selected from cyano, halo, nitro, C.sub.1-4 alkyl and
C.sub.1-4 alkoxy), --C(O)R.sup.9a or --C(O)OR.sup.9b; [0089]
R.sup.9a and R.sup.9b independently represent C.sub.1-6 alkyl;
[0090] A represents C.sub.1-4 alkylene; [0091] B represents -Z-,
-Z-N(R.sup.12)--, -Z-S(O).sub.2-- or -Z-O--; [0092] R.sup.12
represents H or methyl; [0093] R.sup.5 represents pyridyl or
phenyl, which latter group is optionally substituted by one to
three substituents selected from cyano, nitro, C.sub.1-2 alkoxy,
NH.sub.2 and --N(H)S(O).sub.2CH.sub.3.
[0094] Values of R.sup.1 that are more preferred still include an
amino protective group, or a structural fragment of formula Ia in
which: [0095] R.sup.3 represents H, --OR.sup.6 or --N(H)R.sup.7;
[0096] R represents H or phenyl (optionally substituted by one or
more substituents selected from cyano and C.sub.1-2 alkoxy); [0097]
R.sup.7 represents H, phenyl (optionally substituted by one or more
cyano groups) or --C(O)O--C.sub.1-5 alkyl; [0098] A represents
C.sub.1-3 alkylene; [0099] B represents -Z-, -Z-N(H)--,
-Z-S(O).sub.2-- or -Z-O--; [0100] R.sup.5 represents phenyl
substituted by cyano in the ortho- and/or, in particular,
thepara-position relative to B.
[0101] Particularly preferred values of R.sup.1 include an amino
protective group, or a structural fragment of formula Ia in which:
[0102] R.sup.3represents H or --OH; [0103] R.sup.4 represents H;
[0104] A represents CH.sub.2; [0105] B represents -Z-, -Z-N(H)-- or
-Z-O--; [0106] Z represents a direct bond or C.sub.1-2 alkylene;
[0107] R.sup.5 represents para-cyanophenyl.
[0108] Especially preferred values of R.sup.1 include an amino
protective group, or the following sub-structures ##STR6##
[0109] The process of the invention is most preferably carried out
to provide compounds of formula I in which R.sup.1 is an amino
protective group as defined above, such as benzyl.
[0110] Preferred values of R.sup.2 include C.sub.1-6 alkyl,
particularly saturated C.sub.1-6 alkyl.
[0111] More preferred values of R.sup.2 include saturated C.sub.3-5
alkyl, particularly saturated C.sub.4 alkyl, such as
tert-butyl.
[0112] Preferred values of R.sup.1-6 include phenyl, optionally
substituted by one or more (e.g. one to three) substituents (e.g.
one substituent) selected from C.sub.1-3 alkyl (e.g. methyl), halo
and nitro, particularly unsubstituted phenyl, methylphenyl (such as
4-methylphenyl) or trimethylphenyl (such as
2,4,6-trimethylphenyl).
[0113] The process of the invention is preferably carried out in
the presence of a suitable solvent system. This solvent system
should not give rise to stereochemical changes in the reactants or
product once formed.
[0114] For reaction between compounds of formula II and compounds
of formula III, the following may be the case. [0115] (a) Suitable
solvents include water and organic solvents. Preferred solvents
include DMF, N-methylpyrrolidinone, dichloromethane, acetonitrile,
DMSO, lower alkyl (e.g. C.sub.1-6 alkyl) alcohols (such as
ethanol), lower alkyl (e.g. C.sub.1-6 alkyl) esters (e.g. C.sub.1-6
alkyl acetates (such as iso-propyl acetate)), water, aromatic
hydrocarbons (such as toluene) or mixtures thereof. Particularly
preferred solvents include iso-propyl acetate, water, toluene and
mixtures thereof. [0116] (b) Reaction may be carried out in the
presence of a base. In this respect, suitable bases include
tertiary amines such as tri(C.sub.1-6 alkyl)amines (e.g.
triethylamine), alkali metal carbonates and alkali metal
hydrogencarbonates and alkali metal hydroxides. Preferred bases
include alkali metal hydrogencarbonates, such as sodium
hydrogencarbonate, and alkali metal hydroxides, such as sodium
hydroxide. [0117] (c) Reaction is preferably carried out at, or
above, ambient temperature (e.g. between 10 and 100.degree. C.,
preferably between 15 and 85.degree. C., and, particularly, between
20 and 75.degree. C.). For example, where the solvent system that
is employed is a mixture of water and toluene, the reaction may be
carried out at between 55 and 75.degree. C. (such as between 65 and
70.degree. C.). Where the solvent system is toluene (alone), the
reaction may be carried out at between 60 and 70.degree. C. [0118]
(d) The stoichiometric ratio of the compound of formula II to the
compound of formula III is preferably within the range of 3:2 to
2:3, particularly within the range 5:4 to 8:11 (such as within the
range 11:10 to 5:6), and, especially, within the range 1:1 to
10:11, such as 1:1. [0119] (e) Reaction may, if appropriate be
followed by isolation of the appropriate sulfonic acid salt. We
have found advantageously that where reaction takes place between a
compound of formula II in which R.sup.1 is an amino protective
group, such as benzyl, and a compound of formula III in which
R.sup.2 represents tert-butyl and R.sup.16 represents
2,4,6-trimethylphenyl, the resultant sulfonic acid salt may be
readily isolated in high purity by way of simple filtration,
particularly when the compounds of formulae II and III are reacted
together by heating in the presence of an aromatic hydrocarbon,
such as toluene as solvent. [0120] (f) Irrespective of whether the
sulfonic acid salt is isolated, reaction may be followed by
neutralisation of that salt under appropriate conditions, such as
those described hereinafter.
[0121] For reaction between compounds of formula II and acrylamide,
the following may be the case. [0122] (A) Suitable solvents include
polar solvents such as DMF, N-methyl-pyrrolidinone, acetonitrile,
DMSO, lower alkyl (e.g. C.sub.1-6 alkyl) alcohols (such as
ethanol), water, and mixtures thereof. Preferred solvents include
C.sub.1-4 alkyl alcohols such as ethanol. [0123] (B) Reaction is
preferably carried out in the absence of base, although a suitable
base (such as a tertiary amine (e.g. triethylamine)) may be
employed where the compound of formula II is provided as an acid
addition salt. [0124] (C) Reaction is preferably carried out at
above ambient temperature, such as between room and reflux
temperature of the solvent employed (e.g. between 25 and
100.degree. C., preferably between 45 and 90.degree. C., and,
particularly, between 60 and 85.degree. C.). For example, where the
solvent system that is employed is ethanol, the reaction may be
carried out at around reflux temperature (such as between 65 and
80.degree. C., and, particularly, between 70 and 80.degree. C.).
[0125] (D) The stoichiometric ratio of the compound of formula II
to acrylamide is preferably within the range of 3:2 to 2:3,
particularly within the range 5:4 to 8:11 (such as within the range
11:10 to 5:6), and, especially, within the range 1:1 to 10:11 (such
as within the range 1:1 to 20:21. [0126] (E) The intermediate
compound of formula IV that is formed may be purified by
conventional techniques, such as recrystallisation. Suitable
solvents for such a recrystallisation procedure include C.sub.3-8
alkyl esters (such as n-propyl acetate, iso-propyl acetate and,
particularly, ethyl acetate).
[0127] When the intermediate formed by reaction between compounds
of formula II and acrylamide (the compound of formula IV) is
reacted with a brominating agent, base and the alcohol of formula
R.sup.2--OH, the following may be the case. [0128] (i) Reaction is
optionally carried out in the presence of a suitable solvent
system. However, it is preferred that the alcohol R.sup.2--OH is
present in excess such that it may act both as a reagent and as a
solvent for the compound of formula IV. [0129] (ii) Suitable
brominating agents include any source of `electrophilic` bromine,
and thus include bromine and N-bromoimido compounds. Preferred
brominating agents include N-bromosuccinimide. [0130] (iii)
Suitable bases include alkali metal hydroxides and alkoxides.
Preferred bases include alkali metal C.sub.1-6 alkoxides, such as
potassium C.sub.3-5 alkoxides (e.g. potassium tert-butoxide).
[0131] (iv) Reaction is preferably carried out at above ambient
temperature, such as between room and reflux temperature of the
solvent employed (e.g. between 25 and 100.degree. C., preferably
between 45 and 90.degree. C. and, particularly, between 55 and
80.degree. C.). For example, when the alcohol is tert-butanol, the
reaction may be carried out at between 55 and 70.degree. C.,
preferably between 57 and 67.degree. C. and, particularly, between
60 and 65.degree. C. [0132] (v) The stoichiometric ratio of the
compound of formula IV to the brominating agent is preferably
within the range 1:1 to 1:7, particularly within the range 2:3 to
1:5 (such as within the range 1:2 to 1:3) and, especially, within
the range 2:5 to 7:20. [0133] (vi) The stoichiometric ratio of the
compound of formula IV to the base is preferably within the range
1:1 to 1:20, particularly within the range 1:2 to 1:10 (such as
within the range 1:3 to 2:15) and, especially, within the range
5:27 to 1:7.
[0134] Compounds of formula II may be prepared as described in
international patent application WO 01/28992.
[0135] For example compounds of formula II may be prepared by
dehydrative cyclisation of a corresponding compound of formula V,
##STR7## or a protected (e.g. N-benzenesulfonyl or
N-nitrobenzenesulfonyl (e.g. N-4-nitrobenzenesulfonyl) derivative
thereof, wherein R.sup.1 is as hereinbefore defined. This
cyclisation may be carried out, for example in the presence of a
suitable dehydrating agent (such as: a strong acid (e.g. sulfuric
acid (e.g. concentrated sulfuric acid) or, particularly,
methanesulfonic acid (especially anhydrous methanesulfonic acid)
and the like); an acid anhydride such as acetic anhydride or
trifluoromethane-sulfonic anhydride; P.sub.2O.sub.5 in
methanesulfonic acid; a phosphorous-based halogenating agent such
as P(O)Cl.sub.3, PCl.sub.3 or PCl.sub.5; or thionyl chloride). The
cyclisation may also be carried out in the presence of a suitable
organic solvent system, which solvent system should not
significantly react chemically with, or significantly give rise to
stereochemical changes in, the reactant or product once formed, or
significantly give rise to other side reactions. Preferred solvent
systems include aromatic solvents (e.g. an aromatic hydrocarbon,
such as toluene or xylene, or a chlorinated aromatic hydrocarbon,
such as chlorobenzene or dichlorobenzene), or dichloroethane,
optionally in the presence of further solvents such as ethanol
and/or ethyl acetate. When the dehydrating agent is methanesulfonic
acid, preferred solvent systems include toluene. When the
dehydrating agent is sulfuric acid, preferred solvent systems
include chlorobenzene or no solvent. The cyclisation may be carried
out at elevated temperature (e.g. up to the reflux temperature of
the relevant solvent system, or higher if a pressurised system is
employed). Clearly, appropriate reaction times and reaction
temperatures depend upon the solvent system that is employed, as
well as the reactants that are used and the compound that is to be
formed, but these may be determined routinely by the skilled
person.
[0136] Compounds of formula II in which R.sup.1 represents H or an
amino protective group may alternatively be prepared according to,
or by analogy with, known techniques, such as reaction of a
compound of formula VI, ##STR8## wherein R.sup.1a represents H or
an amino protective group (as hereinbefore defined) and L.sup.1
represents a suitable leaving group (e.g. halo, such as iodo), with
ammonia or a protected derivative thereof (e.g. benzylamine), for
example under conditions such as those described in Chem. Ber.
96(11), 2827 (1963).
[0137] Compounds of formula II in which R.sup.1 represents a
structural fragment of formula Ia may alternatively be prepared by
reaction of the compound of formula II in which R.sup.1 represents
H (9-oxa-3,7-diazabicyclo[3.3.1]nonane), or a derivative that is
protected at the other nitrogen atom, with a compound of formula
VII, ##STR9## wherein L.sup.2 represents a leaving group (e.g.
mesylate, tosylate, mesitylenesulfonate or halo) and R.sup.3,
R.sup.4, R.sup.5, A and B are as hereinbefore defined, for example
at between -10.degree. C. and reflux temperature (e.g. between room
temperature and reflux temperature) in the presence of a suitable
base (e.g. triethylamine or an alkali metal hydrogencarbonate or
carbonate, such as K.sub.2CO.sub.3) and an appropriate organic
solvent (e.g. dichloromethane, acetonitrile, DMSO, chloroform,
dimethylformamide, a lower (e.g. C.sub.1-6) alkyl alcohol (such as
ethanol or iso-propanol), or mixtures thereof).
[0138] Compounds of formula II in which R.sup.1 represents a
structural fragment of formula Ia in which A represents C.sub.2
alkylene and R.sup.3 and R.sup.4 together represent .dbd.O may
alternatively be prepared by reaction of
9-oxa-3,7-diazabicyclo[3.3.1]nonane, or a N-protected derivative
thereof, with a compound of formula VIII, ##STR10## wherein R.sup.5
and B are as hereinbefore defined, for example at room temperature
in the presence of a suitable organic solvent (e.g. ethanol).
[0139] Compounds of formula II in which R.sup.1 represents a
structural fragment of formula Ia in which A represents CH.sub.2
and R.sup.3 represents --OH or --N(H)R.sup.7 may alternatively be
prepared by reaction of 9-oxa-3,7-diazabicyclo[3.3.1]-nonane, or a
N-protected derivative thereof, with a compound of formula IX,
##STR11## wherein Y represents O or N(R.sup.7) and R.sup.4,
R.sup.5, R.sup.7 and B are as hereinbefore defined, for example at
elevated temperature (e.g. 60.degree. C. to reflux) in the presence
of a suitable solvent (e.g. a lower (e.g. C.sub.1-6) alkyl alcohol
(e.g. IPA), acetonitrile, water, toluene, a mixture of a lower
(e.g. C.sub.1-6) alkyl alcohol and water, or a mixture of a lower
(e.g. C.sub.1-6) alkyl alcohol and toluene).
[0140] Other compounds of formula II in which R.sup.1 represents a
structural fragment of formula Ia may alternatively be prepared by
known techniques, for example according to techniques described in
WO 01/28992, or by analogy with relevant processes known in the art
for the introduction, and/or chemical conversion, of corresponding
side-chains into, and/or in (as appropriate), corresponding
bispidine compounds, for example as described in international
patent application numbers WO 99/31100, WO 00/76997, WO 00/76998,
WO 00/76999 and WO 00/77000, the disclosures in all of which
documents are hereby incorporated by reference.
[0141] Compounds of formula III may be prepared by reaction of a
corresponding compound of formula X, ##STR12## wherein R.sup.2 is
as hereinbefore defined, with a compound of formula XI,
R.sup.16--S(O).sub.2-L.sup.3 XI wherein L.sup.3 represents a
leaving group (e.g. halo, such as chloro) and R.sup.16 is as
hereinbefore defined, for example at between -20.degree. C. (e.g.
-10.degree. C.) and room temperature in the presence of a suitable
solvent (e.g. a chlorinated hydrocarbon such as dichloromethane),
an appropriate base (e.g. a tertiary amine such as triethylamine)
and a suitable catalyst (e.g. 4-(dimethyl-amino)pyridine or,
preferably, a tertiary amine acid addition salt such as
trimethylamine hydrochloride (see Tetrahedron 55, 2183 (1999)).
[0142] Compounds of formula V in which R.sup.1 represents H or an
amino protective group may be prepared by reaction of
bis(2-oxiranylmethyl)amine (formula XII), ##STR13## or a protected
(e.g. a N-benzenesulfonyl, or a N-nitrobenzenesulfonyl, such as a
N-4-nitrobenzenesulfonyl) derivative thereof, with a compound of
formula XIII, R.sup.1a--N.sup.2 XIII wherein R.sup.1a is as
hereinbefore defined. This reaction may be carried out at between
room temperature and the reflux temperature of any solvent that is
employed (preferably at or around reflux temperature). Suitable
solvent systems that may be employed include organic solvent
systems, which systems should not significantly react chemically
with, or significantly give rise to stereochemical changes in, the
reactants or product once formed, or significantly give rise to
other side reactions. Preferred solvent systems include hydroxylic
compounds such as ethanol, methanol, propan-2-ol, or mixtures
thereof (such as industrial methylated spirit (IMS)), optionally in
the presence of an appropriate co-solvent (e.g. an ester, such as
ethyl acetate, an aromatic solvent, such as toluene or
chlorobenzene, or water). Preferred solvents for this reaction
include primary alcohols such as methanol, propanol and,
especially, ethanol, and preferred co-solvents include toluene and
chlorobenzene.
[0143] Compounds of formula V in which R.sup.1 represents a
structural fragment of formula la may be prepared from the
corresponding compound of formula V in which R.sup.1 represents H
(3,7-dihydroxy-1,5-diazacyclooctane) by known techniques (e.g. by
analogy with the processes described herein in respect of the
preparation of compounds of formula II). In such reactions,
3,7-dihydroxy-1,5-diazacyclooctane is optionally obtained via
deprotection of a compound of formula V in which R.sup.1 represents
an amino protective group.
[0144] Compounds of formula VI may be prepared by known techniques,
for example according to or by analogy with the procedures
described in Chem. Ber. 96(11), 2827 (1963) and international
patent application WO 01/28992.
[0145] Compounds of formula VII may be prepared by standard
techniques. For example, compounds of formula VII in which: [0146]
(1) B represents -Z-O-- may be prepared by coupling a compound of
formula XIV, R.sup.5--OH XIV [0147] wherein R.sup.5 is as
hereinbefore defined, to a compound of formula XV,
L.sup.2-Z-C(R.sup.3)(R.sup.4)-A-L.sup.2 XV [0148] wherein R.sup.3,
R.sup.4, A, Z and L.sup.2 are as hereinbefore defined, and the two
L.sup.2 groups may be the same or different; or [0149] (2) B
represents --N(R.sup.12)-Z- (wherein N(R.sup.12) is attached to the
carbon atom bearing R.sup.3 and R.sup.4) and R.sup.3 and R.sup.4
together represent .dbd.O may be prepared by coupling a compound of
formula XVI R.sup.5-Z-N(H)R.sup.12 XVI [0150] wherein R.sup.5,
R.sup.12 and Z are as hereinbefore defined, to a compound of
formula XVII, L.sup.4-C(O)-A-L.sup.2 XVII [0151] wherein L.sup.4
represents a suitable leaving group (e.g. --OH or halo) and A and
L.sup.2 are as hereinbefore defined, [0152] in both cases, under
conditions which are well known to those skilled in the art.
[0153] Compounds of formula VII in which A represents C.sub.2
alkylene and R.sup.3 represents --OR.sup.6, in which R.sup.6
represents C.sub.1-6 alkyl, -E-aryl or -E-Het.sup.1 may
alternatively be prepared by reaction of a compound of formula
XVIII, R.sup.6a--OH XVIII wherein R represents C.sub.1-6 alkyl,
-E-aryl or -E-Het.sup.1, and E and Het.sup.1 are as hereinbefore
defined, with a compound of formula XIX, ##STR14## wherein R.sup.17
represents C.sub.1-4 alkyl, and R.sup.4, R.sup.5 and B are as
hereinbefore defined, for example at between ambient temperature
(e.g. 25.degree. C.) and reflux temperature in the presence of a
suitable base (e.g. potassium carbonate) and an appropriate organic
solvent (e.g. acetonitrile), followed by conversion of the ester
functionality to a --CH.sub.2-L.sup.2 group (in which L.sup.2 is as
hereinbefore defined), under conditions that are well known to
those skilled in the art.
[0154] Compounds of formula VII in which A represents C.sub.2-6
alkylene may be prepared by reduction of a corresponding compound
of formula XX, ##STR15## wherein A.sup.a represents a direct bond
or C.sub.1-4 alkylene, and R.sup.3, R.sup.4, R.sup.5 and B are as
hereinbefore defined, with a suitable borane or borane-Lewis base
complex (e.g. borane-dimethyl sulfide) in the presence of an
appropriate solvent (e.g. diethyl ether, THF, or a mixture
thereof), followed by oxidation of the resulting borane adduct with
a suitable oxidising agent (e.g. sodium perborate) and then
conversion of the resulting OH group to an L.sup.2 group under
conditions known to those skilled in the art.
[0155] Compounds of formula VII in which A represents C.sub.1-6
alkylene and B represents -Z-N(R.sup.12)-- (in which latter case Z
is attached to the carbon atom bearing R.sup.3 and R.sup.4) may be
prepared by coupling a compound of formula XXI, R.sup.5-L.sup.5 XXI
wherein L.sup.5 represents a leaving group such as halo,
alkanesulfonate, perfluoroalkanesulfonate or arenesulfonate and
R.sup.5 is as hereinbefore defined, with a compound of formula
XXII, HN(R.sup.12)-Z-C(R.sup.3)(R.sup.4)-A.sup.b-OH XXII wherein
A.sup.b represents C.sub.1-6 alkylene, Z, R.sup.3, R.sup.4 and
R.sup.12 are as hereinbefore defined, for example at between room
and reflux temperature, optionally in the presence of a suitable
solvent and/or an appropriate base, followed by conversion of the
OH group to an L.sup.2 group under conditions known to those
skilled in the art.
[0156] Compounds of formula VII in which B represents -Z-S(O)-- or
-Z-S(O).sub.2-- may be prepared by oxidation of corresponding
compounds of formula VII in which B represents -Z-S--, wherein Z is
as hereinbefore defined, in the presence of an appropriate amount
of a suitable oxidising agent (e.g. mCPBA) and an appropriate
organic solvent.
[0157] Compounds of formula IX may be prepared in accordance with
techniques that are known to those skilled in the art. For example,
compounds of formula IX in which: [0158] (1) B represents
--CH.sub.2O-- and Y represents O may be prepared by reaction of a
compound of formula XIV, as hereinbefore defined, with a compound
of formula XXIII ##STR16## [0159] wherein R.sup.4 and L.sup.5 are
as hereinbefore defined, for example at elevated temperature (e.g.
between 60.degree. C. and reflux temperature) in the presence of a
suitable base (e.g. potassium carbonate or NaOH) and an appropriate
organic solvent (e.g. acetonitrile or toluene/water), or as
otherwise described in the art; [0160] (2) R.sup.4 represents H, B
represents a direct bond, C.sub.1-4 alkylene, -Z-N(R.sup.12)--,
-Z-S(O).sub.n-- or -Z-O-- (in which, in each case, the group Z
represents C.sub.1-4 alkylene attached to the carbon atom bearing
R.sup.4) and Y represents O may be prepared by reduction of a
compound of formula XXIVA or XXIVB, ##STR17## [0161] wherein
B.sup.a represents -Z.sup.a-N(R.sup.12), -Z-.sup.a-S(O).sub.n-- or
Z.sup.a-O-- (in which, in each case, the group Z.sup.a represents a
direct bond or C.sub.1-3 alkylene attached to the carbon atom
bearing R.sup.4), B.sup.b represents a direct bond or C.sub.1-4
alkylene, and R.sup.5, R.sup.12 and n are as hereinbefore defined,
for example at between -15.degree. C. and room temperature in the
presence of a suitable reducing agent (e.g. NaBH.sub.4) and an
appropriate organic solvent (e.g. THF), followed by an internal
displacement reaction in the resultant intermediate, for example at
room temperature in the presence of a suitable base (e.g. potassium
carbonate) and an appropriate organic solvent (e.g. acetonitrile);
[0162] (3) B represents a direct bond, C.sub.1-4 alkylene,
-Z-N(R.sup.12)--, -Z-S(O).sub.2-- or -Z-O-- (in which, in each
case, the group Z represents C.sub.1-4 alkylene attached to the
carbon atom bearing R.sup.4) and Y represents O may be prepared by
oxidation of a compound of formula XXVA or XXVB, ##STR18## [0163]
wherein R.sup.4, R.sup.5 and B.sup.b are as hereinbefore defined,
and B.sup.a is as hereinbefore defined except that n represents 2,
in the presence of a suitable oxidising agent (e.g. mCPBA), for
example by refluxing in the presence of a suitable organic solvent
(e.g. dichloromethane); or [0164] (4) B represents -Z-O--, in which
group Z represents C.sub.1-4 alkylene attached to the carbon atom
bearing R.sup.4, and Y represents --N(R.sup.7), wherein R.sup.7
represents --C(O)OR.sup.9b or --S(O).sub.2R.sup.9c, may be prepared
by cyclisation of a compound of formula XXVI, ##STR19## [0165]
wherein R.sup.7a represents --C(O)OR.sup.9b or
--S(O).sub.2R.sup.9c, Z.sup.b represents C.sub.1-4 alkylene and
R.sup.4, R.sup.5, R.sup.9b, R.sup.9c and L.sup.5 are as
hereinbefore defined, for example at between 0.degree. C. and
reflux temperature in the presence of a suitable base (e.g. sodium
hydroxide), an appropriate solvent (e.g. dichloromethane, water, or
a mixture thereof) and, if necessary, a phase transfer catalyst
(such as tetrabutylammonium hydrogensulfate).
[0166] Bis(2-oxiranylmethyl)amine (the compound of formula XII) may
be prepared by reaction of two or more equivalents of a compound of
formula XXVII, ##STR20## [0167] wherein L.sup.3 is as hereinbefore
defined, with ammonia, or a protected (e.g. a benzenesulfonyl, or a
nitrobenzenesulfonyl (e.g. a 4-nitrobenzenesulfonyl)) derivative
thereof, for example at between room and reflux temperature in the
presence of a suitable base (e.g. an alkali metal carbonate such as
cesium carbonate, sodium hydroxide, sodium hydride or lithium
diisopropylamide), an appropriate solvent (e.g. acetonitrile,
N,N-dimethylformamide, THF, toluene, water or mixtures thereof),
and optionally in the presence of a phase transfer catalyst (e.g.
tricaprylylmethylammonium chloride). Preferred bases include sodium
hydroxide and preferred solvents include water.
[0168] Compounds of formula XX in which B represents C.sub.1-4
alkylene may be prepared by coupling a compound of formula XXVIII,
##STR21## wherein B.sup.c represents C.sub.1-4 alkylene, Hal
represents chloro, bromo or iodo, and A.sup.a, R.sup.3 and R.sup.4
are as hereinbefore defined, with a compound of formula XXI, as
hereinbefore defined, for example at between -25.degree. C. and
room temperature in the presence of a suitable zinc(II) salt (e.g.
anhydrous ZnBr.sub.2), an appropriate catalyst (e.g.
Pd(PPh.sub.3).sub.4 or Ni(PPh.sub.3).sub.4) and a reaction-inert
organic solvent (e.g. THF, toluene or diethyl ether).
[0169] Compounds of formulae VIII, X, XI, XIII, XIV, XV, XVI, XVII,
XVIII, XIX, XXI, XXII, XXIII, XXIVA, XXIVB, XXVA, XXVB, XXVI, XXVII
and XXVIII, and derivatives thereof, are either commercially
available, are known in the literature or may be obtained by
analogy with the processes described herein, or by conventional
synthetic procedures, in accordance with standard techniques, from
readily available starting materials using appropriate reagents and
reaction conditions.
[0170] As stated above, the process of the invention is preferably
carried out to produce compounds of formula I in which R.sup.1
represents an amino protective group, such as benzyl.
[0171] A preferred synthesis of compounds of formula I, however,
involves synthesis of compounds of formula I in which R.sup.1
represents a structural fragment of formula Ia, as hereinbefore
defined, which process comprises the formation of a compound of
formula I in which R.sup.1 represents H or, preferably, an amino
protective group (which should subsequently be removed to form a
compound of formula I in which R.sup.1 is H) and subsequent
coupling of the resultant "intermediate" compound of formula I with
a compound that provides the structural fragment of formula Ia, for
example as described herein.
[0172] Thus, according five further aspects of the invention there
is provided: [0173] (I) a process for the preparation of a compound
of formula I in which R.sup.1 represents H, which process comprises
removal of the amino protective group from a corresponding compound
of formula I in which R.sup.1 represents an amino protective group;
[0174] (II) a process for the preparation of a compound of formula
I in which R.sup.1 represents H, which process comprises a process
as described hereinbefore for the preparation of a corresponding
compound of formula I in which R.sup.1 represents an amino
protective group followed by removal of the amino protective group;
[0175] (III) a process for the preparation of a compound of formula
I in which R represents [0176] a) a structural fragment of formula
Ia, [0177] b) a structural fragment of formula Ia, in which A
represents C.sub.2 alkylene and R.sup.3 and R.sup.4 together
represent .dbd.O, or [0178] c) a structural fragment of formula Ia,
in which A represents CH.sub.2 and R.sup.3 represents --OH or
--N(H)R.sup.7, [0179] which process comprises reaction of a
corresponding compound of formula I in which R.sup.1 represents H
with [0180] 1) a compound of formula VII, as hereinbefore defined,
[0181] 2) a compound of formula VIII, as hereinbefore defined, or
[0182] 3) a compound of formula IX, as hereinbefore defined,
respectively; [0183] (IV) a process for the preparation of a
compound of formula I in which R.sup.1 represents [0184] a) a
structural fragment of formula Ia, [0185] b) a structural fragment
of formula Ia, in which A represents C.sub.2 alkylene and R.sup.3
and R.sup.4 together represent .dbd.O, or [0186] c) a structural
fragment of formula Ia, in which A represents CH.sub.2 and R.sup.3
represents --OH or --N(H)R.sup.7, [0187] which process comprises a
process for the preparation of a corresponding compound of formula
I in which R.sup.1 represents H, as described hereinbefore,
followed by reaction of that compound with [0188] 1) a compound of
formula VII, as hereinbefore defined, [0189] 2) a compound of
formula VIII, as hereinbefore defined, or [0190] 3) a compound of
formula IX, as hereinbefore defined, respectively; and [0191] (V) a
process for the preparation of a compound of formula I in which
R.sup.1 represents [0192] a) a structural fragment of formula Ia,
[0193] b) a structural fragment of formula Ia, in which A
represents C.sub.2 alkylene and R.sup.3 and R.sup.4 together
represent .dbd.O, or [0194] c) a structural fragment of formula Ia,
in which A represents CH.sub.2 and R.sup.3 represents --OH or
--N(H)R.sup.7, [0195] which process comprises a process as
described hereinbefore for the preparation of a corresponding
compound of formula I in which R.sup.1 represents an amino
protective group, removal of the amino protective group and
subsequent coupling of the resulting compound of formula I in which
R.sup.1 represents H, with [0196] 1) a compound of formula VII, as
hereinbefore defined, [0197] 2) a compound of formula VIII, as
hereinbefore defined, or [0198] 3) a compound of formula IX, as
hereinbefore defined, respectively.
[0199] In these further aspects of the invention, amino protective
groups may be removed under standard conditions. For example, when
the amino protective group is benzyl, deprotection may be carried
out by hydrogenation at ambient temperature in the presence of a
suitable catalyst (e.g. a supported palladium catalyst, such as
Pd/C, e.g. 5% (w/w) Pd/C), an appropriate solvent (e.g. a lower
(e.g. C.sub.1-6) alkyl alcohol, such as ethanol, or an aromatic
hydrocarbon, such as toluene, or mixtures thereof) and optionally
in the presence of a suitable base (e.g. an alkali metal carbonate
or hydrogencarbonate, such as sodium hydrogencarbonate).
Deprotection may also be carried out in the presence of a suitable
acid. Strong acids (e.g. HCl) may be used, though we prefer that
the acid is a weaker acid, such as citric acid and the like.
[0200] Further, coupling between a compound of formula I in which
R.sup.1 represents H and a compound of formula VII, VIII or IX may
take place under any of the relevant conditions described
hereinbefore in respect of respective preparations of corresponding
compounds of formula II.
[0201] In particular, where coupling takes place between a compound
of formula I in which R.sup.1 represents H and a compound of
formula VII, then the coupling is preferably carried out at between
65 and 75.degree. C. (such as at 70.degree. C.) in the presence of
a C.sub.1-6 alkyl alcohol (such as ethanol) as solvent and an
alkali metal carbonate (such as K.sub.2CO.sub.3) base.
[0202] Further, where coupling takes place between a compound of
formula I in which R.sup.1 represents H and a compound of formula
IX, then the coupling is preferably carried out at between 50 and
80.degree. C. (such as at between 60 and 75.degree. C., such as
70.degree. C. (e.g. 66.degree. C. or 70.degree. C.)) in the
presence of a C.sub.1-6 alkyl alcohol (such as iso-propanol or
ethanol), water and/or toluene as solvent, and optionally in the
presence of a suitable base (e.g. NaOH). Preferred solvents for
this reaction include mixtures of iso-propanol and water, and
mixtures of ethanol, water and toluene.
[0203] In addition to the further aspects of the invention
described above, the skilled person will appreciate that certain
compounds of formula I may be prepared from certain other compounds
of formula I or from structurally related compounds. For example,
compounds of formula I in which RI represents certain structural
fragments of formula Ia may be prepared in accordance with relevant
processes known in the art for the interconversion of corresponding
structural fragments of formula Ia, for example by analogy with the
processes described in international patent application numbers WO
99/31100, WO 00/76997, WO 00/76998, WO 00/76999, WO 00/77000 and WO
01/28992.
[0204] It will be appreciated by those skilled in the art that, in
the processes described above, the functional groups of
intermediate compounds may be, or may need to be, protected by
protecting groups. In particular, it may be desirable to protect
the amino group of bis(2-oxiranylmethyl)amine (the compound of
formula XII) with an appropriate protecting group (e.g.
benzenesulfonyl, nitrobenzenesulfonyl (such as
4-nitrobenzenesulfonyl)), which should be removed after the
compound of formula II is formed.
[0205] In any event, functional groups which it is desirable to
protect include hydroxy and amino. Suitable protecting groups for
hydroxy include trialkylsilyl and diarylalkylsilyl groups (e.g.
tert-butyldimethylsilyl, tert-butyldiphenylsilyl or
trimethylsilyl), tetrahydropyranyl and alkylcarbonyl groups (e.g.
methyl- and ethylcarbonyl groups). Suitable protecting groups for
amino include the amino protective groups mentioned hereinbefore,
such as benzyl, sulfonyl (e.g. benzenesulfonyl or
4-nitrobenzenesulfonyl), tert-butyloxycarbonyl,
9-fluorenylmethoxycarbonyl or benzyloxycarbonyl.
[0206] The protection and deprotection of functional groups may
take place before or after any of the reaction steps described
hereinbefore.
[0207] Protecting groups may be removed in accordance with
techniques which are well known to those skilled in the art and as
described hereinafter.
[0208] The use of protecting groups is fully described in
"Protective Groups in Organic Chemistry", edited by J. W. F.
McOmie, Plenum Press (1973), and "Protective Groups in Organic
Synthesis", 3.sup.rd edition, T. W. Greene & P. G. M. Wutz,
Wiley-Interscience (1999).
[0209] The process of the invention possesses the surprising
advantage that compounds of formula I may be prepared conveniently
from solid (as opposed to, for example, oily or semi-solid)
precursors, which precursors may be purified using simple
procedures (e.g. recrystallisation).
[0210] Further, the process of the invention may have the advantage
that compounds of formula I may be prepared in higher yields, by
way of fewer steps, in less time, more conveniently, and at a lower
cost, than when prepared according to the process described in
international patent application WO 01/28992.
[0211] The invention is illustrated, but in no way limited, by the
following examples.
EXAMPLES
General Experimental Procedures
[0212] Mass spectra were recorded on one of the following
instruments: a Waters ZMD single quad with electrospray (S/N
mc350); a Perkin-Elmer SciX API 150ex spectrometer; a VG Quattro II
triple quadrupole; a VG Platform II single quadrupole; or a
Micromass Platform LCZ single quadrupole mass spectrometer (the
latter three instruments were equipped with a pneumatically
assisted electrospray interface (LC-MS)). .sup.1H NMR and .sup.13C
NMR measurements were performed on Varian 300, 400 and 500
spectrometers, operating at .sup.1H frequencies of 300, 400 and 500
MHz respectively, and at .sup.13C frequencies of 75.5, 100.6 and
125.7 MHz respectively.
[0213] Rotamers may or may not be denoted in spectra depending upon
ease of interpretation of spectra. Unless otherwise stated,
chemical shifts are given in ppm with the solvent as internal
standard.
Preparation A
2-(tert-Butyloxycarbonylamino)ethyl tosylate
[0214] A solution of p-toluenesulfonyl chloride (28.40 g, 148 mmol)
in dichloromethane (100 mL) was added dropwise over 30 minutes at
0.degree. C. to a mixture of tert-butyl N-(2-hydroxyethyl)carbamate
(20 g, 120 mmol), triethylamine (18.80 g, 186 mmol) and
trimethylammonium chloride (1.18 g, 12.4 mmol) in dichloromethane
(120 mL). The mixture was stirred at 0.degree. C. for 1 hour then
filtered, washing with dichloromethane (100 mL). The filtrate was
washed with 10% citric acid (3.times.100 mL) and brine (100 mL).
The organic layer was dried with magnesium sulfate and then
filtered. The filtrate was concentrated under reduced pressure to
give an oil. The oil was dissolved in ethyl acetate (40 mL) and
then iso-hexane (160 mL) was added slowly. The resultant slurry was
stirred at room temperature for 17 hours and then filtered. The
collected solid was washed with iso-hexane (240 mL) to yield the
title compound as a colourless powder (25 g, 64%).
[0215] m.p. 64-66.degree. C.
[0216] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 1.40 (9H, s), 2.45
(3H, s), 3.38 (2H, q), 4.07 (2H, t), 4.83 (1H, bs) 7.34 (2H, d),
7.87 (2H, d).
[0217] MS: m/z=216 (MH.sup.+(316)-Boc).
Preparation B
3-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
(i) NN-Bis(2-oxiranylmethyl)benzenesulfonamide
[0218] Water (2.5 L, 10 vol.) followed by epichlorohydrin (500 mL,
4 eq.) were added to benzenesulfonamide (250 g, 1 eq.). The
reactants were heated to 40.degree. C. Aqueous sodium hydroxide
(130 g in 275 mL of water) was added such that the temperature of
the reaction remained between 40.degree. C. and 43.degree. C. This
took approximately 2 hours. (The rate of sodium hydroxide addition
needs to be slower at the start of the addition than at the end in
order to keep within the temperature range stated.) After the
addition of sodium hydroxide was complete, the reaction was stirred
at 40.degree. C. for 2 hours, then at ambient temperature
overnight. The excess epichlorohydrin was removed as a water
azeotrope by vacuum distillation (ca. 4 kPa (40 mbar), internal
temp 30.degree. C.), until no more epichlorohydrin distilled.
Dichloromethane (1L) was added and the mixture stirred rapidly for
15 minutes. The phases were allowed to separate (this took 10
minutes although totally clear phases are obtained after standing
overnight). The phases were separated and the dichloromethane
solution used in the subsequent step below.
[0219] .sup.1H NMR (400 MHz, CDCl.sub.3): .delta. 2.55-2.65 (2H,
m), 2.79 (2H, t, J 4.4), 3.10-3.22 (4H, m), 3.58-3.73 (2H, m),
7.50-7.56 (2H, m), 7.58-7.63 (1H, m), 7.83-7.87 (2H, m).
(ii)
5-Benzyl-3,7-dihydroxy-1-phenylsulfonyl-1,5-diazacyclooctane
[0220] IMS (2.5 L, 10 vol) was added to the dichloromethane
solution from step (i) above. The solution was distilled until the
internal temperature reached 70.degree. C. Approximately 1250 mL of
solvent was collected. More IMS (2.5 L, 10 vol) was added followed
by benzylamine (120 mL, 0.7 eq.) in one portion (no exotherm seen),
and the reaction was heated at reflux for 6 hours (no change from 2
hour sampling point). More benzylamine was added (15 mL) and the
solution was heated for a further 2 hours. The IMS was distilled
off (ca. 3.25 L) and toluene was added (2.5 L). More solvent was
distilled (ca. 2.4 L) and then further toluene added (1 L). The
head temperature was now 110.degree. C. A further 250 mL of solvent
was collected at 110.degree. C. Theoretically, this left the
product in ca. 2.4 L of toluene at 110.degree. C.
[0221] This solution was used in the next step.
[0222] .sup.1H NMR (400 MHz, CDCl.sub.3): .delta. 7.83-7.80 (4H, m,
ArH), 7.63-7.51 (6H, m, ArH), 7.30-7.21 (10H, ArH), 3.89-3.80 (4H,
m, CH(a)+CH(b)), 3.73 (2H, s, CH.sub.2Ph(a)), 3.70 (2H, s,
CH.sub.2Ph(b)), 3.59 (2H, dd, CHHNSO.sub.2Ar(a)), 3.54 (2H, dd,
CHHNSO.sub.2Ar(b)), 3.40 (2H, dd, CHHNSO.sub.2Ar(b)), 3.23 (2H, dd,
CHHNSO.sub.2Ar(a)), 3.09-2.97 (4H, m, CHHNBn(a)+CHHNBn(b)), 2.83
(2H, dd, CHHNBn(b)), 2.71 (2H, dd, CHHNBn(a))
[0223] (Data taken from purified material comprising a 1:1 mixture
of trans- (a), and cis-diol (b))
(iii)
3-Benzyl-7-(phenylsulfonyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane
[0224] The toluene solution from the previous step (ii) above was
cooled to 50.degree. C. Anhydrous methanesulfonic acid (0.2 L) was
added. This caused a temperature rise from 50.degree. C. to
64.degree. C. After 10 minutes, methanesulfonic acid was added (1
L) and the reaction heated to 110.degree. C. for 5 hours. Toluene
was then distilled from the reaction; 1.23 L was collected. (Note
that the internal temperature should not be allowed higher than
110.degree. C. at any stage otherwise the yield will be decreased.)
The reaction was then cooled to 50.degree. C. and a vacuum applied
to remove the rest of the toluene. Heating to 110.degree. C. and 65
kPa (650 mbar) allowed a further 0.53 L to be removed. (If the
toluene can be removed at a lower temperature and pressure then
that is beneficial.) The reaction was then left to cool to
30.degree. C. and deionised water (250 mL) was added. This caused
the temperature to rise from 30.degree. C. to 45.degree. C. More
water (2.15 L) was added over a total time of 30 minutes such that
the temperature was less than 54.degree. C. The solution was cooled
to 30.degree. C. and then dichloromethane (2 L) was added. With
external cooling and rapid stirring, the reaction mixture was
basified by adding aqueous sodium hydroxide (10 M, 2 L) at a rate
that kept the internal temperature below 38.degree. C. This took 80
minutes. The stirring was stopped and the phases separated in 3
minutes. The layers were partitioned. IMS (2 L) was added to the
dichloromethane solution and distillation started. Solvent (2.44 L)
was collected until the head temperature reached 70.degree. C.
Theoretically, this left the product in 1.56 L of IMS. The solution
was then allowed to cool to ambient temperature overnight with slow
stirring. The solid product that precipitated was filtered and
washed with IMS (0.5 L) to give a fawn-coloured product that, on
drying at 50.degree. C., in vacuum, gave 50.8 g (8.9% over 3
steps).
[0225] 20.0 g of this product was dissolved in acetonitrile (100
mL) at reflux to give a pale yellow solution. After cooling to
ambient temperature, the crystals that formed were collected by
filtration and washed with acetonitrile (100 mL). The product was
dried in vacuo at 40.degree. C. for 1 hour to give 17.5 g (87%) of
sub-title compound.
[0226] .sup.1H NMR (400 MHz, CDCl.sub.3): .delta. 7.18-7.23 (1OH,
m), 3.86-3.84 (2H, m), 3.67 (2H, d), 3.46 (2H, s), 2.91 (2H, d),
2.85 (2H, dd), 2.56 (2H, dd)
(iv) 3-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
dihydrochloride
[0227] Concentrated hydrobromic acid (1.2 L, 3 rel. vol.) was added
to solid
3-benzyl-7-(phenylsulfonyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane
(400 g, see step (iii) above) and the mixture was heated to reflux
under a nitrogen atmosphere. The solid dissolved in the acid at
95.degree. C. After heating the reaction for 8 hours, HPLC analysis
showed that the reaction was complete. The contents were cooled to
room temperature. Toluene (1.2 L, 3 rel. vol.) was added and the
mixture stirred vigorously for 15 minutes. Stirring was stopped and
the phases were partitioned. The toluene phase was discarded along
with a small amount of interfacial material. The acidic phase was
returned to the original reaction vessel and sodium hydroxide (10
M, 1.4 L, 3.5 rel. vol.) was added in one portion. The internal
temperature rose from 30.degree. C. to 80.degree. C. The pH was
checked to ensure it was >14. Toluene (1.6 L, 4 rel. vol.) was
added and the temperature fell from 80.degree. C. to 60.degree. C.
After vigorous stirring for 30 minutes, the phases were
partitioned. The aqueous layer was discarded along with a small
amount of interfacial material. The toluene phase was returned to
the original reaction vessel, and 2-propanol (4 L, 10 rel. vol.)
was added. The temperature was adjusted to between 40.degree. C.
and 45.degree. C. Concentrated hydrochloric acid (200 mL) was added
over 45 minutes such that the temperature remained at between
40.degree. C. and 45.degree. C. A white precipitate formed. The
mixture was stirred for 30 minutes and then cooled to 7.degree. C.
The product was collected by filtration, washed with 2-propanol
(0.8 L, 2 rel vol.), dried by suction and then further dried in a
vacuum oven at 40.degree. C. Yield=297 g (91%).
[0228] .sup.1H NMR (CD.sub.3OD+4 drops D.sub.2O): .delta. 2.70 (br
d, 2H), 3.09 (d, 2H), 3.47 (br s, 4H), 3.60 (s, 2H), 4.12 (br s,
2H), 7.30-7.45 (m, 5H).
[0229] API MS: m/z=219 [C.sub.13H.sub.18N.sub.2O+H].sup.+.
(v) 3-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
[0230] All volumes and equivalents are measured with respect to the
amount of 3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
dihydrochloride (see step (iv) above) used. Toluene (420 mL, 7
vols) and aqueous sodium hydroxide solution (2M, 420 mL, 7 vols,
4.0 eq) were added to 3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
dihydrochloride (60.07 g, 206.03 mmole, 1.0 eq., see step (iv)
above). The mixture was stirred under nitrogen, heated to
60.degree. C. and held at this temperature for 30 minutes by which
time two clear layers had formed. The lower, aqueous layer was
removed, and the toluene solution of title compound (free base) was
azeodried at atmospheric pressure (total volume of solvent
removed=430 mL; total volume of toluene added=430 mL), then
concentrated to a volume of 240 mL (4 vols). Karl Fischer analysis
at this stage showed 0.06% water in the solution. The dried
solution of title compound (theoretically 44.98 g, 206.03 mmole,
1:0 eq) was used as such in a subsequent step.
Preparation C
3-(4-Cyanoanilino)propyl 4-methylbenzenesulfonate
Alternative I
(i) 4-[(3-Hydroxypropyl)amino]benzonitrile
[0231] A mixture of 4-fluorobenzonitrile (12.0 g, 99.1 mmol) and
3-amino-1-propanol (59.6 g, 793 mmol) was stirred at 80.degree. C.
under an inert atmosphere for 3 hours before water (150 mL) was
added. The mixture was allowed to cool to rt, and was then
extracted with diethyl ether. The organic layer was separated,
dried (Na.sub.2SO.sub.4), filtered and concentrated in vacuo to
yield 17 g (97%) of the sub-title compound as an oil that
crystallised upon standing.
(ii) 3-(4-Cyanoanilino)propyl 4-methylbenzenesulfonate
[0232] A cooled (0.degree. C.) solution of
4-[(3-hydroxypropyl)amino]benzonitrile (from step (i) above; 17 g,
96.5 mmol) in dry MeCN (195 mL) was treated with triethylamine (9.8
g, 96.5 mmol) and then p-toluenesulfonyl chloride (20.2 g, 106
mmol). The mixture was stirred at 0.degree. C. for 90 minutes
before being concentrated in vacuo. Water (200 mL) was added to the
residue, and the aqueous solution was extracted with DCM. The
organic phase was dried (Na.sub.2SO.sub.4), filtered and
concentrated in vacuo. The resulting residue was purified by
crystallisation from iso-propanol to yield 24.6 g (77%) of the
title compound.
Alternative II
(a) 4-[(3-Hydroxypropyl)amino]benzonitrile
[0233] 4-Fluorobenzonitrile (24.6 g, 0.203 mol, Aldrich 99%) was
added to 3-amino-1-propanol (122.0 g, 1.625 mol, 8 equiv., Aldrich
99%) and the mixture heated to 80.degree. C. for 5 hours, under
nitrogen. The solution was allowed to cool to 22.degree. C. and
water (300 mL) was added. The cloudy solution was extracted twice
with methylene chloride (300 mL and 200 mL) and the combined
methylene chloride extracts were washed with water (300 mL) (Note
1).
(b) 3-(4-Cyanoanilino)propyl 4-methylbenzenesulfonate
[0234] The solution of the crude
4-[(3-hydroxypropyl)amino]benzonitrile (see step (a) above) was
concentrated to a volume of 300 mL by distillation and a further
200 mL methylene chloride added and redistilled to 300 mL (Note 2).
Triethylamine (20.55 g, 0.203 mol), followed by
4-(N,N-dimethyl-amino)pyridine (248 mg, 2.0 mmol) was added and the
solution was cooled to 0.degree. C. A solution of tosyl chloride
(38.70 g, 0.203 mol) in methylene chloride (150 mL) added over ca.
30 minutes with cooling and good agitation, allowing the
temperature to rise to 5.degree. C. The reaction was stirred for 23
hours in the range 3 to 5.degree. C. (Note 3) under nitrogen. Water
(300 mL) was added and the layers vigorously agitated for 15 min.
The organic solution was concentrated by distillation at 35 to
40.degree. C. to a volume of ca. 60 to 70 mL. iso-Propanol (100 mL)
was added over 5 minutes (Note 4). Distillation was continued using
house vacuum to remove the last of the methylene chloride (Note 5).
The crystal slurry was cooled to 0 to 5.degree. C. over ca. 1 hour
with slow agitation and held for one hour at 0-5.degree. C. The
crystals were filtered on a medium sinter and the compacted damp
filter cake carefully washed with cold (0.degree. C.) iso-propanol
(80 mL). The filter cake was dried under vacuum and a stream of
nitrogen overnight. Yield: 52.6 g, 78.4 mole %; HPLC: 99.64 area
%.
Notes:
[0235] 1. GC analysis of organic layer gave .about.1.0 area %
aminopropanol remaining. [0236] 2. Solution water by KF 0.07%
[0237] 3. After 5 hours, triethylamine hydrochloride precipitation
occurred. TLC showed very little if any further conversion of
residual cyano alcohol at 20-23 hours. [0238] 4. At this stage,
some granular precipitation of product occurred prior to addition
of iso-propanol. Crystallization occurred rapidly upon addition of
iso-propanol. [0239] 5. A further .about.30 mL was
removed--distillate checked by GC for absence of methylene
chloride. [0240] 6. Microanalysis: found (theory): %C: 61.60
(61.67); % H: 5.41 (5.49); % N: 8.44 (8.47); %S: 9.71(9.70).
Preparation D
4-[(2S)-Oxiranylmethoxy]benzonitrile
[0241] Potassium carbonate (414 g) and (R)-(-)-epichlorohydrin (800
mL) were added to a stirred solution of p-cyanophenol (238 g) in
2.0 L MeCN and the reaction mixture was refluxed under an inert
atmosphere for 2 h. The hot solution was filtered and the filtrate
concentrated, giving a clear oil which was crystallised from
di-iso-propyl ether giving the product in 90% yield.
Preparation E
2-(tert-Butyloxycarbonylamino)ethyl
2,4,6-trimethylbenzenesulfonate
[0242] Triethylamine (65 mL, 465.3 mmole, 1.5 eq) was added in one
portion to a solution of tert-butyl N-(2-hydroxyethyl)carbamate
(50.11 g, 310.2 mmole, 1.0 eq.) in dichloromethane (250 mL, 5
vols). The solution was cooled to -10.degree. C. and trimethylamine
hydrochloride (14.84 g, 155.1 mmole, 0.5 eq.) was added in one
portion. The resultant mixture was cooled further to -15.degree.
C., stirred for 5 minutes, then treated with a solution of
mesitylenesulfonyl chloride (74.74 g, 341.2 mmole, 1.1 eq) in
dichloromethane (250 mL, 5 vols), over 28 minutes such that the
internal temperature remained below -10.degree. C. Once the
addition was complete a precipitate had formed and the mixture was
stirred at -10.degree. C. for a further 30 minutes. Water (400 mL,
8 vols) was added and all of the precipitate dissolved. The mixture
was stirred rapidly for 5 minutes, and then the two layers were
separated. A solvent swap from dichloromethane to IPA was carried
out by distillation at reduced pressure. Solvent was removed (450
mL) and replaced with IPA (450 mL) (initial pressure was 450 mbar,
b.p. 24.degree. C.; final pressure was 110 mbar, b.p. 36 .degree.
C.). At the end of the distillation, solvent (150 mL) was removed
to bring the volume down to 350 mL (7 vols with respect to the
amount of tert-butyl N-(2-hydroxyethyl)carbamate used). The
solution was cooled to 25.degree. C., then water (175 mL) was added
slowly with stirring, causing the solution gradually to turn
cloudy. No solid had precipitated at this stage. More water (125
mL) was added, and a solid precipitate started to form after about
75 mL had been added. The internal temperature rose from 25.degree.
C. to 31.degree. C. The mixture was stirred slowly and cooled to
7.degree. C. The solid was collected by filtration, washed with
IPA:water (1:1, 150 mL) and dried in vacuo at 40.degree. C. for 21
hours to give the title compound as a white crystalline solid
(92.54 g, 87%).
[0243] m.p. 73.5.degree. C.
[0244] .sup.1H-NMR (300MHz, CDCl.sub.3) .delta. 1.42 (9H, s), 2.31
(3H, s), 2.62 (6H, s) 3.40 (2H, q), 4.01 (2H, t), 4.83 (1H, bs),
6.98 (2H, s)
Example 1
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester via nucleophilic substitution reaction
Alternative I
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester
[0245] A solution of 3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
dihydro-chloride (see Preparation B(iv) above; 10 g, 34 mmol) in
water (25 mL) was added slowly to a solution of sodium bicarbonate
(10 g, 119 mmol) in water 10 mL). More water (5 mL) was added and
the mixture was stirred at room temperature for 10 minutes. A
solution of 2-(tert-butyloxycarbonylamino)-ethyl tosylate (see
Preparation A above; 11.92 g, 37 mmol) in toluene (40 mL) was
added. This mixture was then heated at 65-70.degree. C. for 7 hours
before stirring at room temperature overnight. The reaction was
reheated to 50.degree. C. and the phases were separated. The
aqueous layer was extracted with toluene (40 mL) at 50.degree. C.
The combined organic layers were washed with saturated sodium
bicarbonate (25 mL). The solvents were evaporated under reduced
pressure to yield a mixture of oil and solid (13 g, >100%).
Ethyl acetate (50 mL) and citric acid (10%, 25 mL) were added to a
portion of the oily solid (5 g, 138 mmol). The aqueous layer was
separated and the organic layer washed again with citric acid (10%,
20 mL). The aqueous layers were combined and treated with solid
sodium bicarbonate until neutral. The aqueous phase was extracted
with ethyl acetate (2.times.50 mL), dried over magnesium sulfate
and filtered. The filtrate was evaporated to dryness under reduced
pressure to give the title compound as a colourless semi-solid,
which solidified fully when stored in the refrigerator (4.68 g,
93%).
[0246] m.p. 58-60.degree. C.
[0247] .sup.1H-NMR (300MHz, CDCl.sub.3) .delta. 1.46 (9H, s),
2.38-2.57 (4H, m), 2.6-2.68 (2H, m) 2.75-2.85 (4H, m), 3.22 (2H,
q), 3.26 (2H, s), 3.83 (2H, bs), 6.17 (1H, bs) 7.2-7.4 (5H, m).
[0248] MS: m/z =362 (MH.sup.+).
Alternative II
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester, 2,4,6-trimethylbenzenesulfonic acid salt
[0249] A warm (28.degree. C.) solution of
2-(tert-butyloxycarbonylamino)ethyl 2,4,6-trimethylbenzenesulfonate
(70.93 g, 206.03 mmole, 1.0 eq, see Preparation E above) in toluene
(240 mL, 4 vols) was added to a solution of
3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane (44.98 g, 206.03
mmole, 1.0 eq.) in toluene (240 mL, 4 vols) (see Preparation B
above). The resultant solution was stirred rapidly under nitrogen,
with heating at 68.degree. C. for 8 hours. The reaction was left to
stir at ambient temperature for 84 hours. A thick, white solid
precipitate had formed in a pale yellow solution. The mixture was
cooled to +9.degree. C., and title compound was collected by
filtration. The reaction vessel was washed with toluene (100 mL)
and added to the filter. The filter cake was washed with toluene
(150 mL). The white solid product was suction dried for 15 minutes,
then dried to constant weight in vacuo at 40.degree. C. for 23
hours. The yield of title compound obtained was 79.61 g, 141.7
mmole, 69%. The combined filtrate and washings (670 mL) were washed
with aqueous sodium hydroxide solution (2M, 200 mL, 3.3 vols). The
mixture was heated to 60.degree. C., and held at this temperature
for 20 minutes with rapid stirring. The two layers were then
separated. The toluene solution was concentrated to 200 mL by
vacuum distillation (bp 50-54.degree. C. at 650-700 mbar; bp
46.degree. C. at 120 mbar at the end). As the distillation
progressed, the solution became cloudy due to the formation of
title compound. It was assumed that 20% of the original amount of
3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane remained in the
filtrate, and so extra 2-(tert-butyloxycarbonylamino)ethyl
2,4,6-trimethylbenzenesulfonate (14.20 g, 41.21 mmole, 0.2 eq) was
added in one portion (charged as a solid rather than as a solution
in toluene). The cloudy solution was heated at 67.degree. C. for 8
hours with rapid stirring, and then left to stir at ambient
temperature for 11 hours. The mixture was cooled to +8.degree. C.,
and title compound was collected by filtration. The reaction vessel
was washed with more toluene (2.times.30 mL), and added to the
filter. The white solid product was suction dried for 15 minutes,
then dried to constant weight in vacuo at 40.degree. C. for 7
hours. The yield of title compound was 23.25 g, 41.39 mmole, 20%.
The combined yield of title compound (a white solid) was 102.86 g,
183.11 mmole, 89%. m.p. 190-190.5.degree. C.
[0250] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 1.43 (9H, s), 2.17
(3H, s), 2.51 (6H, s), 2.73-2.80 (2H, m), 2.90-2.94 (4H, m),
3.14-3.22 (4H, m), 3.37 (2H, bm), 3.89 (2H, bs), 4.13 (2H, bs),
6.74 (2H, s), 7.12 (1H, bt), 7.42-7.46 (5H, m)
Example 2
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester via Michael addition of acrylamide
(i)
3-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)propionamide
[0251] Triethylamine (3.60 g, 35.7 mmol) was added slowly to a
solution of 3-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
dihydrochloride (see Preparation B(iv) above; 5 g, 17 mmol) in
ethanol (50 mL). Acrylamide (1.34 g, 18 mmol) was added to this
mixture, which was then heated at reflux for 7 hours. The reaction
mixture was then concentrated under reduced pressure. Water (50 mL)
and sodium hydroxide (1 M, 150 mL) were added to the residue and
the mixture extracted with ethyl acetate (2.times.200 mL). The
combined organic extracts were dried over magnesium sulfate,
filtered and concentrated under reduced pressure to give a
colourless solid. This was recrystallised from ethyl acetate (50
mL) to give the sub-title compound (3.80 g, 76%).
[0252] m.p. 157-159.degree. C.
[0253] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 2.39 (2H, t),
2.42-2.61 (6H, m), 2.82-2.95 (4H, m), 3.39 (2H, s), 3.91 (2H, bs),
5.07 (1H, bs), 7.18-7.21 (2H, m), 7.25-7.39 (3H, m), 9.5 (1H,
bs).
[0254] MS: m/z =290 (MH.sup.+).
(ii)
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester
[0255] N-Bromosuccinimide (6.0 g, 33 mmol) was added in portions
over 1 minute to a solution of
3-(7-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-propionamide
(see step (i) above; 5 g, 12 mmol) in potassium tert-butoxide in
tert-butanol (1 M, 81 mL) and tert-butanol (20 mL). The mixture was
then heated at 60-65.degree. C. for 30 minutes. The reaction was
allowed to come to room temperature and then water (100 mL) was
added. The mixture was extracted with ethyl acetate (2.times.50
mL). The combined organic extracts were washed with brine (50 mL),
dried over magnesium sulfate, filtered (washing the filter cake
with ethyl acetate (50 mL)) and then the filtrate concentrated
under reduced pressure to give the title compound as a brown oil
(6.5 g, >100%).
[0256] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 1.46 (9H, s),
2.4-2.58 (4H, m), 2.58-2.7 (2H, m) 2.75-2.91 (4H, m), 3.22 (2H, q),
3.28 (2H, s), 3.83 (2H, bs), 6.19 (1H, bs) 7.2-7.42 (5H, m).
[0257] MS: m/z=316 (MH.sup.+).
Example 3
[2-(9-Oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic acid
tert-butyl ester
Alternative I
[0258] Sodium bicarbonate (0.058 g, 0.069 mmol) and 5% Pd/C (0.250
g, Johnson Matthey Type 440 paste) were added to a solution of
[2-(7-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester (see Example 1 (Alternative I) above; 1 g,
2.77 mmol) in ethanol (10 mL). The mixture was then hydrogenated at
500 kPa (5 bar) for 18 hours. The reaction mixture was filtered
through Celite.RTM. and then washed with ethanol (20 mL). The
solution was concentrated under reduced pressure to give an oil.
This was dissolved in dichloromethane (20 mL) and washed with
sodium hydroxide (1 M, 10 mL). The organic phase was separated,
dried over magnesium sulfate and then filtered. The filtrate was
concentrated under reduced pressure to give the title compound as a
yellow solid (0.67 g, 87%).
[0259] m.p. 91-93.degree. C.
[0260] .sup.1H-NMR (300MHz, CDCl.sub.3) .delta. 1.46 (9H, s), 2.25
(2H, t), 2.58-2.65 (2H, m) 2.95-3.06 (4H, m), 3.2-3.38 (4H, m),
3.64 (2H, bs), 4.65 (1H, bs).
[0261] MS: m/z =272 (MH.sup.+).
Alternative II
[0262]
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester 2,4,6-trimethylbenzenesulfonic acid salt (320
g, 1.0 mol eq, 1.0 rel vol/wt, see Example 1 (Alternative II)
above), toluene (640 mL, 2.0 vol) and aqueous sodium hydroxide (1M,
1.6 L, 5.0 vol) were stirred together for 15 minutes and the layers
were then separated. The organic layer, containing
[2-(7-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]carbamic
acid tert-butyl ester, was diluted with ethanol (690 mL, 2.16 vol)
and water (130 mL, 0.4 vol). Citric acid (32.83g, 0.3 mol eq) and
5% Pd/C (20.8 g, 0.065 wt eq of 61% water wet catalyst, Johnson
Matthey type 440L) were added. The combined mixture was then
hydrogenated under 4 bar of hydrogen pressure for 24 hours. The
reaction was monitored by TLC, using a silica plate with mobile
phase X:DCM (1:1 v/v; X is chloroform:methanol:concentrated ammonia
80:18:2 v/v). Visualisation was by UV light (254 nm) and by
staining with aqueous potassium permanganate. This showed the
complete disappearance of starting material and the appearance of
the title compound. The reaction mixture was filtered through
kieselguhr and was washed with ethanol (590 mL, 1.84 vol). The
resulting solution of title compound (assumed 154.85 g, 100%) was
used directly in a subsequent reaction.
Alternative III
[0263]
[2-(7-Benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbami-
c acid tert-butyl ester 2,4,6-trimethylbenzenesulfonic acid salt
(50 g, 1.0 mol eq., 1.0 rel vol/wt, see Example 1 (Alternative II)
above), toluene (100 mL, 2.0 vol) and aqueous sodium hydroxide (1M,
100 L, 2.0 vol) were stirred together for 20 minutes, then at
30.degree. C. for 10 minutes, and the layers were then separated.
The organic layer, containing
[2-(7-benzyl-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic
acid tert-butyl ester, was diluted with ethanol (100 mL, 2.0 vol.).
To this was added a solution of citric acid (5.14 g, 0.3 mol eq) in
water (5 mL, 0.1 vol), followed by 5% Pd/C (1.50 g, 0.03 wt eq of
61% water wet catalyst, Johnson Matthey type 440L). The combined
mixture was then hydrogenated under 4 bar of hydrogen pressure for
24 hours. The reaction was monitored by TLC, using a silica plate
with mobile phase X:DCM 1:1 v/v, (X is chloroform:
methanol:concentrated ammonia 80 :18:2 v/v). Visualisation was by
UV light (254 m-n) and by staining with aqueous potassium
permanganate. This showed the complete disappearance of starting
material and the appearance of the title compound. The reaction
mixture was basified with aqueous sodium hydroxide (10M, 8 mL, 0.9
mol eq), then filtered through kieselguhr. The filter-cake was
washed with ethanol (100 mL, 2.0 vol). The resulting solution of
title compound (assumed 24.15 g, 100%) was used directly in a
subsequent reaction.
Example 4
(2-{7-[3-(4-Cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}-et-
hyl)carbamic acid tert-butyl ester
Alternative 1
[0264] 3-(4-Cyanoanilino)propyl-4-methylbenzenesulfonate (see
Preparation C above; 0.30 g, 0.92 mmol) and potassium carbonate
(0.2 g, 1.38 mmol) were added to a solution of
[2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic acid
tert-butyl ester (see Example 3 (Alternative I) above; 0.250 g,
0.92 mmol) in ethanol (5 mL). The reaction mixture was heated to
70.degree. C. for 10 hours before concentrating the mixture under
reduced pressure. The residue was partitioned between ethyl acetate
(20 mL) and sodium hydroxide (1 M, 10 mL). The aqueous phase was
re-extracted with ethyl acetate (20 mL). The combined organic
phases were concentrated under reduced pressure to give a yellow
solid (0.290 g). The solid was dissolved in ethyl acetate (10 mL)
and this solution washed with a solution of citric acid (0.250 g)
in water (10 mL). The aqueous phase was separated, basified with
sodium hydroxide (1 M, 10 mL) and extracted with ethyl acetate
(2.times.10 mL). All organic phases were combined, dried over
magnesium sulfate and then filtered (washing filtered solids with
ethyl acetate (10 ML)). The filtrate was concentrated under reduced
pressure to give a yellow solid (0.160 g). This was slurried in
ethyl acetate (0.2 mL) and then filtered to give title compound
(0.050 g, 12%).
[0265] m.p 113-115.degree. C.
[0266] .sup.1H-NMR (400 MHz, DMSO-D.sub.6) .delta. 1.32 (9H, s),
1.7 (2H, qt), 2.20 (2H, t), 2.22-2.3 (4H, m), 2.38-3.1 (2H, m)
2.8-2.85 (4H, m), 3.05 (2H, q), 3.19 (2H, q), 3.79 (2H, bs), 6.47
(1H, t), 6.66 (2H, d), 6.69 (1H, t), 7.41 (2H, d).
[0267] MS: m/z=430 (MH.sup.+).
Alternative 2
(a) 3-(4-Cyanoanilino)propyl benzenesulfonate
[0268] To the solution of 4-[(3-hydroxypropyl)amino]benzonitrile
(see Preparation C above (first steps of both Alternatives);
assumed 43.65 g, 247.7 mmol, 1.0 eq) in dichloromethane (360 mL
total solution volume) was added, sequentially, triethylamine (52
mL, 37.60 g, 371.55 mmol, 1.5 eq) and trimethylamine hydrochloride
(11.89 g, 123.85 mmol, 0.5 eq) in one portion. The yellow solution
was cooled to -20.degree. C. (using a cold plate), and treated with
a solution of benzenesulfonyl chloride (32 mL, 43.74 g, 247.7 mmol,
1.0 eq) in dichloromethane (220 mL, 5 vols with respect to the
cyanoalcohol) via a pressure equalising dropping funnel. The
solution was added portionwise such that the internal temperature
did not exceed -14.degree. C. The addition took 25 minutes to
complete. The mixture was then stirred for 35 minutes at between
-15 and -10.degree. C. Water (365 mL) was added and the temperature
rose to 10.degree. C. The mixture was cooled back to 0.degree. C.
and stirred vigorously for 15 minutes. The organic layer (volume
570 mL) was collected and distilled at atmospheric pressure to
remove DCM (450 mL, pot temperature 40-42.degree. C., still-head
temperature 38-39.degree. C.). Ethanol (250 mL) was added, and the
solution was allowed to cool to below 30.degree. C. before turning
on the vacuum. More solvent was removed (40 mL was collected,
pressure 5.2 kPa (52 mbar), pot and still-head temperatures were
21-23.degree. C.), and the product gradually came out of solution.
The distillation was stopped at this point, and more ethanol (50
mL) was added. The mixture was warmed (hot water bath at 50.degree.
C.) to 40.degree. C. to dissolve all the solid, and water (90 mL)
was added slowly via a dropping funnel. The solution was stirred
slowly at room temperature (20.degree. C.) overnight (15 hours), by
which time some product had crystallised out. The mixture was
cooled to -5.degree. C. (ice/methanol bath) and stirred at this
temperature for 20 minutes before collecting the pale yellow solid
by filtration. The solid was washed with an ethanol/water mixture
(42 mL EtOH, 8 mL H.sub.2O), and suction dried for 30 minutes
before drying to constant weight in the vacuum oven (40.degree. C.,
72 hours). The mass of crude product obtained was 47.42 g (149.9
mmol, 60%). Ethanol (160 mL, 8 vols) was added to the crude product
(20.00 g, 63.22 mmol, 1.0 eq). The mixture was stirred under
nitrogen and warmed to 40.degree. C. using a hot water bath. On
reaching this temperature, all of the solid had dissolved to give a
clear, yellow solution. Water (60 mL, 3 vols) was added dropwise
over a period of 10 minutes, whilst the internal temperature was
maintained in the range 38-41.degree. C. The water bath was
removed, and the solution was allowed to cool to 25.degree. C. over
40 minutes, by which time crystallisation had begun. The mixture
was cooled to -5.degree. C. over 10 minutes, then held at this
temperature for a further 10 minutes. The pale yellow solid was
collected by filtration, suction dried for 10 minutes, then dried
to constant weight in a vacuum oven (40.degree. C., 15 hours). The
mass of sub-title compound obtained was 18.51 g (58.51 mmol, 93%
(from the crude product)).
(b)
(2-{7-[3-(4-Cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl-
}-ethyl)carbamic acid tert-butyl ester
[0269] To the solution of
[2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic acid
tert-butyl ester generated in Example 3 (Alternative III) above
(assumed 24.15 g, 1.0 mol eq., 1.0 wt./vol.) in a mixture of
toluene (approx. 100 mL), ethanol (approx. 200 mL) and water
(approx. 14 mL), was added anhydrous potassium carbonate (18.58 g,
1.5 mol eq.). Solid 3-(4-cyanoanilino)propyl-4-benzenesulfonate
(28.17 g, 1.0 mol eq., see step (a) above) was added and the
combined mixture was heated to 70.degree. C. for six hours. The
reaction was monitored by TLC using a silica plate with mobile
phase X:DCM 1:1 v/v (in which X is chloroform:methanol:concentrated
ammonia 80:18:2 v/v). Visualisation was by UV light (254 nm) and by
staining with aqueous potassium permanganate. This showed the
complete disappearance of starting material and the appearance of
the title compound. The reaction mixture was cooled, and the
solvent was concentrated in vacuo. The residue was partitioned
between toluene (200 mL) and water (200 mL). The layers were
separated, and the organic phase was concentrated in vacuo to
afford a yellow solid (38.6 g). This was dissolved in iso-propanol
(190 mL, 5.0 rel. vol.) at 60.degree. C., and the hot solution was
filtered. The filtrate was stirred, and left to cool to room
temperature. A white solid crystallised. The mixture was cooled
from room temperature to approximately 8.degree. C. The product was
collected by filtration and was washed with iso-propanol (50 mL,
2.0 vol.). The damp product was dried in vacuo at 40.degree. C. to
constant weight to give the title compound as a white crystalline
solid (30.96 g, 81%).
[0270] m.p. 113.5.degree. C.
[0271] .sup.1H-NMR (400 MHz, CD.sub.3OD) .delta. 1.40 (9H, s),
1.81-1.90 (2H, m), 2.35-2.54 (8H, m), 2.93 (4H, t) 3.18-3.27 (4H,
m), 3.87 (2H, bs), 6.66 (2H, d), 7.39 (2H, d)
[0272] MS: m/z =(MH.sup.+, 430)
Example 5
tert-Butyl
2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazab-
icyclo[3.3.1]non-3-yl}ethylcarbamate
Alternative I
[0273] iso-Propanol (5 mL) and water (0.5 mL) were added to
[2-(9-oxa-3,7-diaza-bicyclo[3.3.1]non-3-yl)ethyl]carbamic acid
tert-butyl ester (see Example 3 (Alternative I) above; 0.43 g, 1.6
mmol) and 4-[(2S)-oxiranylmethoxy]benzonitrile (0.280 g, 1.6 mmol;
see Preparation D above) was added. The mixture was heated at
66.degree. C. for 19 hours (reaction was complete in 2 hours). The
solvent was evaporated to dryness under reduced pressure to give
the title compound as an off-white solid (0.71 g, 100%).
[0274] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 1.41 (9H, s),
2.3-2.75 (6H, m), 2.75-3.0 (5H, m), 3.1-3.38 (3H, m), 3.88 (2H, s),
3.95-4.19 (3H, m), 5.85 (1H, bs), 6.99 (2H, d), 7.6 (2H, d).
[0275] .sup.1H-NMR (300 MHz, DMSO-D.sub.6) .delta. 1.35 (9H, s),
2.12-2.59 (7H, m), 2.63-2.78 (1H, m), 2.78-2.9 (4H, m), 3.2 (2H,
q), 3.78 (2H, m), 4-4.1 (2H, m), 4.12-4.19 (1H, m), 5.3 (1H, bs),
6.61 (1H, t), 7.15 (2H, d), 7.76 (2H, d).
[0276] MS: m/z=447 (MH.sup.+)
Alternative II
[0277] The solution of
[2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic acid
tert-butyl ester generated in Example 3 (Alternative II) above
(assumed 154.85 g, 1.0 mol eq, 1.0 wt/vol) in a mixture of toluene
(approx 640 mL), ethanol (approx 1280 mL) and water (approx 130
mL), was basified with aqueous sodium hydroxide (10M, 51 mL, 0.9
mol eq.). Solid 4-[(2S)-oxiranylmethoxy]benzonitrile (99.80 g, 1.0
mol eq.; see Preparation D above) was added and the combined
mixture was heated to 70.degree. C. for four hours. The reaction
was monitored by TLC using a silica plate with mobile phase X:DCM
1:1 v/v (in which X is chloroform:methanol:concentrated ammonia
80:18:2 v/v). Visualisation was by UV light (254 nm) and by
staining with aqueous potassium permanganate. This showed the
complete disappearance of starting material and the appearance of
the title compound. The reaction mixture was cooled, filtered
through kieselguhr and washed through with ethanol (620 mL, 4.0
vol). This gave a solution of title compound (assumed 254.38 g,
100% th, 2.4 L, 1.0 wt/vol for reaction work up). This solution was
charged into a flask that was set up for reduced pressure
distillation. A graduation line was marked onto the side of this
flask. Solvent (1250 mL) was removed at between 50.degree. C. and
35.degree. C., 320 mbar and 100 mbar. Then 4-methylpentan-2-ol
(1500 mL) was added in order to reach the graduated line. Solvent
(1250 mL) was removed at between 35.degree. C. and 80.degree. C.,
220 mbar and 40 mbar. More 4-methylpentan-2-ol (1500 mL) was added
in order to reach the graduated line. Solvent (1250 mL) was removed
at between 62.degree. C. and 76.degree. C., 100 mbar and 90 mbar.
The combined mixture was cooled to less than 25.degree. C. and
aqueous sodium hydroxide (2M, 1.27 L, 5.0 vol) was added. The
layers were separated and the organic layer was filtered through
kieselguhr to give a clear solution (1.2 L). This solution was
charged into a clean flask, which was set up for reduced pressure
distillation. Solvent (450. mL) was removed at between 52.degree.
C. and 55.degree. C., 90 mbar and 35 mbar. Theoretically, the
product was now left in 2 volumes of 4-methylpentan-2-ol.
Di-n-butyl ether (1.27 L, 5 vol) was added and the solution was
allowed to cool slowly to room temperature, which caused a
precipitate to form. The mixture was cooled from room temperature
to approximately 10.degree. C. The product was collected by
filtration and was washed with a pre-mixed solution of di-n-butyl
ether (320 mL, 1.25 vol) and 4-methylpentan-2-ol (130 mL, 0.50
vol). The damp product was dried in vacuo at 55.degree. C. to
constant weight to give the title compound as a white solid (193.6
g, 76%).
[0278] m.p. 99-101.degree. C.
[0279] .sup.1H-NMR (300 MHz, CDCl.sub.3) .delta. 1.41 (9H, s),
2.3-2.75 (6H, m), 2.75-3.0 (5H, m), 3.1-3.38(3H, m), 3.88 (2H, s),
3.95-4.19 (3H, m), 5.85 (1H, bs), 6.99 (2H, d), 7.6 (2H, d).
Abbreviations
[0280] API=Abbreviations [0281] API=atmospheric pressure ionisation
(in relation to MS) [0282] br=broad (in relation to NMR) [0283]
dd=doublet (in relation to NMR) [0284] DCM=dichloromethane [0285]
dd=doublet of doublets (in relation to NMR) [0286]
DMF=N,N-dimethylformamide [0287] DMSO=dimethylsulfoxide [0288]
Et=ethyl [0289] eq.=equivalents [0290] GC=gas chromatography [0291]
h=hour(s) [0292] HCl=hydrochloric acid [0293] HPLC=high performance
liquid chromatography [0294] IMS=industrial methylated spirit
[0295] IPA=iso-propyl alcohol [0296] KF=Karl-Fischer [0297]
m=multiplet (in relation to NMR) [0298] Me=methyl [0299]
MeCN=acetonitrile [0300] min.=minute(s) [0301] m.p.=melting point
[0302] MS=mass spectroscopy [0303] Pd/C=palladium on carbon [0304]
q=quartet (in relation to NMR) [0305] rt=room temperature [0306]
s=singlet (in relation to NMR) [0307] t=triplet (in relation to
NMR) [0308] TLC=thin layer chromatography [0309] UV=ultraviolet
[0310] Prefixes n-, s-, i-, t- and tert- have their usual meanings:
normal, secondary, iso, and tertiary.
* * * * *